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THERMODYNAMIC MECHANISMS OF HELIX STABILIZATION IN A MODEL PEPTIDE
AND PROTEIN

Abstract

By Ryan Murray
University of the Pacific
2021

Biologics are large, complex therapeutic agents generally produced from living organisms. One
group of biologics is peptide/protein based. Biological agents offer unique advantages over
traditional therapeutics including longer half-lives, higher specificity, greater efficacy, and
reduced off-target effects. However, protein/peptide based drugs suffer from both delivery and
stability issues. The higher order of protein structures (secondary, tertiary, etc.) derive ~80% of
their conformational stability from paltry hydrophobic effects, with net stabilization of 5-15
kcal/mole observed for many proteins. Loss of conformational stability can lead to increased
aggregation, precipitation, and degradation; and reduced activity and side effects. To increase
stability and improve other properties of the therapeutic agent, additives, referred to as
excipients, are included in their formulation. Generally, stabilizing effects from excipients work
by imposing enthalpic or entropic penalties on protein/peptide unfolding, increasing the free
energy of the denatured state. How excipient stabilizes by what thermodynamic mechanism for
a given protein/peptide is not always clear, requiring careful study and optimization for
prospective agents. Much effort has gone into understanding excipient protection mechanisms
and identifying potential liable regions like amino acid sequence and hydrophobic patches. One
area that has received relatively little attention has been the effect of excipients on secondary
structure (SS) thermodynamic stabilization/destabilization. SS features are major components of
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biologic conformation in which deviations, even temporary, can lead to aggregation and
precipitation. In this study, an experimental system is proposed to quantify and classify helix
stabilization in a model peptide and protein. Thermodynamic stability was evaluated via helix
unfolding in the peptide, or protein through use of circular dichromism (CD) and nuclear
magnetic resonance (NMR) for model peptide polyL-lysine (PLL) and CD and differential
scanning calorimetry (DSC) for model protein bovine serum albumin (BSA). The chosen
molecular weight of the PLL polymer, adopts a helical structure, is neutral and a monomeric
under tested conditions, making it an ideal model to evaluate excipient effects on helix stability.
BSA is largely helical in nature, with most changes and aggregation behavior resulting from loss
of helicity, making it a logical extension from the model peptide. Results showed stabilization
from mannitol and trehalose being mainly enthalpically driven in both peptide and protein.
Enthalpic destabilization was observed for PLL and BSA at low to mid concentrations but
stabilizing for PLL and destabilizing for BSA at high concentrations, respectively. Moreover,
use of entropy-enthalpy compensation (EEC) plots revealed primary stabilization mechanisms at
varying excipient concentrations and types allowing for a classification system to be established
under different conditions. Peptide/protein based therapeutics typically exist in a complex milieu
of additives designed to enhance stability and performance, or allow novel delivery methods
(oral, pulmonary, etc.) not typically available to such agents. Ultimately, this work provides a
model for understanding excipient effects on helix stability in a complex system. Further work
into other SS, higher order structures, as well as complex formulation systems in the model
framework described in this work will help to improve the formulation optimization process.
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CHAPTER 1: INTRODUCTION

1.1 Biologics
Traditionally, the pharmaceutical marketplace has been dominated by what is now
considered small molecule drugs. During the industrial revolution, dye manufacturing
companies honed compound identification and organic synthesis techniques, allowing for the
discovery and production of some of the earliest modern therapeutic compounds1. Well over a
century later, myriad such compounds have been developed, produced, and used to treat various
illnesses. Despite the significant number and sheer variety of small molecule drugs on the
market, they share several similarities: i.e. a narrow size range on the order of 200-800 Da.
Their absorption, distribution, metabolism, and excretion (ADME) behavior can often be
predicable by a methodology similar to Lipinski’s rule-of-five principles. Additionally, they are
relatively non-selective and have the potential for off target effects2. Conversely, biologics are
large complex macromolecules ranging in size from 3,000-300,000 kDa. They are generally
produced through appropriately transfected cells, or other living organisms in the form of
peptides, proteins, vaccines, DNA, or RNA rather than chemically synthesized. Moreover, they
are very selective, posing less risk of off target effects3. This work will focus specifically on
protein and peptide biologics.
Amino acid based drugs are a somewhat new class of therapeutics, having been first
introduced in the form of vaccines in the late 19th century. However, with the advent of
monoclonal antibodies, and an ability to express and produce a greater repertoire of peptides and
proteins, the apparent benefits of biologics excited the pharmaceutical industry. This was due to
their extreme specificity, lower risk of off target effects, and ability to address diseases less
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accessible by small molecule compounds. While it is more difficult/expensive to develop and
produce, generic biologic production and generic drug substitution of biologics is still in its
infancy, potentially extending the revenue potential of any new biologic compound relative to
synthetic drugs. Today there are hundreds of biologics on the market, with hundreds more
undergoing clinical trials or development3. Applications for biologics range from cancers,
infectious diseases, blood disorder, skeletal/muscle issues, eye, metabolic, skin, digestive, lung,
and neurological disorders3. Currently, cancer, autoimmune, and infectious diseases comprise
most of the treated ailments. In 2020 the total revenue from biologics are estimated to reached
$313 billion dollars (relative $1,079.3 billion for small molecules)4. In 2016, six of the top eight
revenue earning drugs were biologics5.
Despite their increasing use and percentage of the market share, biologic therapeutics are
often hamstrung due to their fragility. Slight deformation of their conformation or degradation
during any of the production, formulation, or transportation steps can greatly affect efficacy,
stability, and safety of this class of compounds. Moreover, due to these stability issues, biologics
have short shelf storage times, complex transportation considerations (i.e. cold chain
maintenance), and often require some form of extravascular administration. Because of this,
optimizing biologic formulations to achieve required stability is of paramount importance.
Significant effort has gone into understanding stabilization mechanisms of biologics6-13 to
improve and expedite the formulation process. While excipient-biologic interactions are
complex in nature, they can be broken down thermodynamically into two
stabilizing/destabilizing components: enthalpic and entropic. In liquid formulation conditions,
enthalpic and entropic protection mechanisms are described as preferential exclusion/hydration
and crowding effects, respectively9, 11, 14-18. Overall increases from either component increases
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the free energy of unfolding, thereby stabilizing the native conformation. Thermodynamically
speaking, lyophilized and other solid formulations are also stabilized/destabilized enthalpically
and entropically; however, the mechanistic protection mechanisms are more complex and
debated19, 20, but are typically described via water replacement and vitrification theory. A more
detailed discussion on both liquid and solid formulation protection mechanisms will be discussed
in later sections. It should be noted most solid formulations will need to be reconstituted prior to
administration and will need adequate stability in the liquid phase as well.
Complicating the formulation optimization process is the specific interactions between
various biologic agents and stabilizing additives. Buffers, disaccharides, crowding agents,
surfactants, etc., can have different stabilizing/destabilizing effects depending on the
protein/peptide agent being formulated, or the concentration of additive. Understanding how a
given additive stabilizes a biologic therapeutic or specific component of the agent may help to
improve the formulation process. Various studies have looked at factors such as hydrophobic
patches21, amino acid sequences22 as a means to predict stability and excipient interactions;
however, very little work has gone into understanding how secondary structure (SS) is stabilized
in the liquid phase. This is important given that loss of secondary structure in even part, or
temporarily can increase the risk of aggregation and precipitation. Having a general
understanding and classification system to thermodynamically evaluate excipient interactions is
proposed on SS features may help to improve the formulation process.
The present work explores the effects of various excipients on first a model helical
peptide poly-l-lysine (PLL) and classifying said effects using an entropy-enthalpy compensation
(EEC). Results from the PLL model were compared to a model protein bovine serum albumin
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(BSA). Data from both peptide and protein are discussed and used as a means to evaluate and
quantitate excipient interactions with helices in potential biologic therapeutics.

1.2 Characterization of Proteins and Peptides
Proteins are large complex molecules whose properties are largely determined through its
amino acid (AA) sequence and chemical environment. Of the 20 naturally occurring AAs, it can
be observed that there exists a large variance in size, pH, polarity, and hydrophobicity between
them. Additionally, AAs and their accompanying peptide backbone bonds present no stable
geometric features leading to their organization into SS and tertiary structures. The peptide
backbone consists of an amide bond formed from the amine and carboxylic acid groups of two
adjacent amino acids. For labeling purposes, (and because cellular machinery synthesizes
proteins in this direction) the convention is to start numbering AAs from the N-terminal end and
proceed to towards the carboxylic C-terminal in a given sequence. The resulting amide bond
possesses approximately 60% sp2 character making rotation about amide bond impossible23, 24.
As a result, only two conformations are possible between two amino acids: cis, or trans. The
later occurs in nearly all cases, except in the presence of proline in a sequence. Moreover, this
lack of rotation means there is a formation of a plane between the backbone elements of two
amino acids which possess an angle of 180o and a torsional angle (labeled omega ω (see Figure
2.1)). The two other torsional angles phi φ and psi ψ describe the rotational angles between the
amide and alpha carbon and amine and carbonyl atom, respectively (see Figure1.1).
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Figure 1.1 Anatomy of peptide/protein bonding and nomenclature.1

Phi and psi angles can vary from -180o to +180o but are limited due to steric clashes
between the carbonyl oxygen, amide hydrogen, and the alpha carbon hydrogen. Phi angles are
calculated by looking down alpha carbon towards the amide bond and noting the angle between
alpha carbon and i-1 carbonyl. Likewise, psi angles are determined through looking down the
alpha carbon towards the i carbonyl and noting the angle between the i+1 and i amide.
Given the chemical properties of amino acids, peptide back bones, and the torsional
angles they form, we can now discuss the formation of higher order structures such as secondary
structure (SS), tertiary structure, and quaternary structure. As previously stated, the amide bond
creates a plane between adjacent residues, and the phi and psi torsional angles are free to rotate
180o; however, they are affected and limited by steric hindrance from other residue elements
such as backbone features and side chain as well as any favorable/unfavorable solvent
interactions. The angles adopted by the phi and psi are what give rise to SS features. SS
elements such as helices and sheets allow for efficient hydrogen bond formation between
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hydrogen donors and receivers as well as minimize unfavorable hydrophobic interactions with
aqueous solvents.
Tertiary structure comprises all SS elements and the overall folded conformation of the
protein or peptide. Given the varied nature of AA side chains, the phi and psi dihedral angles,
tertiary structure is greatly affected by AA sequences and environmental conditions. For
globular proteins, solvent hydrophobic effect contributes 80% to protein folding25. Some
proteins may even join other proteins creating a quaternary structure as is sometimes the case for
some enzymes and cofactors.
1.3 The Protein Problem
Stability is of paramount importance in the preparation of fragile biologics. Stability can
be classified in two ways: chemical and physical. The latter, physical (conformational) stability
will be the focus of this work; however, physical and chemical stability are often inexorably
linked.
1.4 Chemical Degradation
Chemical degradation is an important consideration for all protein-based therapeutics and
can proceed through myriad pathways. These can be encompassed into broad classifications
such as deamidation, hydrolysis, and oxidation.
Deamidation generally refers to the hydrolysis of an Asp or Gln residue amide side chain.
Such reactions generally proceed via intramolecular cyclization, forming succinimide
intermediate, then undergo amide cleavage8, 9. Deamidation rates are enhanced when the asp
neighbor residues possess small side chains such as glycine, which reduces any steric hindrance
that might otherwise interfere with the cyclization step. Additionally, pH conditions will factor
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in deamidation propensity , requiring careful attention to pH conditions when preparing
biologics with deamidation hotspots.
Hydrolysis proceeds via acid/base catalyzed amide cleavage. Like deamidation, it is
enhanced by asp residues, especially when said residues are adjacent to a proline. It is especially
common in the hinge region of monoclonal antibodies (mAbs), and can be catalyzed with poorly
chosen buffers, radical species present in solution and metal catalysis9.
Oxidation occurs through free radical generation, forming reactive oxygen species (ROS)
which can damage most residues. Sources include metal catalyzing oxidation (MCO) species, as
well as light exposure are common culprits9. Certain residues such as Met and Trp are most
vulnerable to oxidation9.
While degradation types may vary, molecular motion is a common contributor factor
among them. Movement exposes liable sites and the diffusion of degradant material to them. As
such, conformation contributes significantly to degradation rates of proteins and can be a good
predictor of liable hotspots on a biologic compound. Helices, and sheets, reduce molecular
motion of a protein relative to random coils, or disordered regions. Folding and unfolding of a
protein also increase degradation propensity. In light of this, formulations which enhance
conformational stability will in many instances enhance chemical stability.
1.5 Physical Instability
Physical stability is associated with three broad categories: conformational, colloidal and
interfatial26. Conformational instability can occur through thermal stresses, chemical
denaturation, or dehydration. Protein stability is often associated with conformational stability
defined by transition temperature Tm. Essentially, the greater the Tm the more stable the native
structure (though there are many caveats to this axiom that shall be discussed later). Contrary to
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the increasing Tm conditions mentioned above, where folding/unfolding is entropically driven,
cold temperature denaturation at or below the freezing point reduces the hydrophobic effect as
water movement decreases, becoming more ordered around hydrophobic patches as
crystallization begins27. This reduction can stabilize the unfolded state and denature the protein.
Chemical denaturation through contact with chaotropic substances lowers the surface free energy
of protein, thus increasing the concentration of denatured protein states28, 29. Dehydration during
lyophilization removes structure stabilizing water from the protein surface, leading to loss of
SS30, 31. Proteins may possess various charges and dipoles over their surface, leading to
attractive/repulsive interactions affecting their colloidal stability which can be predictive of both
aggregation propensity and solubility26, 29, 32, 33. Surface absorption/interface interaction can
occur under many circumstances such as liquid-ice interfaces, air-water interface from vortexing,
shaking, and container-liquid surface. Such interfaces provide a hydrophobic surface, allowing
for protein unfolding, increasing the risk of protein aggregation and precipitation8, 28, 29, 34, 35.
Protein aggregation can proceed through a variety of mechanisms with varying degrees of
seriousness and is often a product of conformational change. Ultimately, it can lead to
irreversible association, precipitation and inactivation of the desired compound28, 29. Many
mechanisms attempting to explain aggregation have been put forward, and a basic model
illustrating typical aggregation steps and pathways is shown in Figure 1.2.
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Figure 1.2. Peptide/protein aggregation and precipitation pathway. 2

Essentially, proteins can aggregate from the native or conformationally modified
monomer to bi, tri, tetra and higher oligomers that have the potential to be reversible/irreversible.
At a certain point, nucleation can occur, leading to large, insoluble aggregates.
1.6 Thermodynamic Principles
As previously discussed, chemical and physical degradation are major hindrances in the
stability and delivery of biologics. Regardless of pathway, conformation maintenance is critical
towards preserving form and function of such compounds over extended periods of time. Being
large macromolecules with complex and environmentally sensitive features, understanding the
principles behind stabilization is essential for successful formulations strategies. Traditionally,
stabilization can largely be described from well-established thermodynamic principles.
Thermodynamics concerns itself with the relationship of different forms of energy as
described by the three laws of thermodynamics. The first law states that energy is conserved
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when undergoing different interconversion processes. The second law introduces entropy,
followed by the third law which quantifies it36. Energy is a product of intensity factors
(independent of material quantity i.e. temperature and pressure) and a differential of extensive
property (mass and volume) of the system36. Taken together, thermodynamics allows for the
quantification of work done by a system on its surroundings, heat transfer, whether a specific
process/reaction is spontaneous or not, and can describe phase transitions of different substances
under various environmental conditions. An ability to quantitate such factors is invaluable in
evaluating formulation optimization of protein/peptide drugs. Of interest in the stabilization of
proteins is determining the enthalpy, entropy, and Gibbs free energy of unfolding.
1.7 First Law of Thermodynamics
The first law of thermodynamics states that energy is conserved regardless of process or
form that it takes; that it is a state function and can be expressed via equation 1 where E2,and E1,
refer to the final and internal energy of the system, respectively, while Q and W refer to heat and
work, respectively.
∆𝐸 = 𝐸2 − 𝐸1 = 𝑄 + 𝑊 (1.1)
Further examination of equation 1 allows the observation that work and heat are two
equivalent ways of energy form interchange of a system. Being able to describe and quantitate
the internal energy of a system is important in that it allows an understanding of how a system is
behaving. For example, internal energy encompasses the microscopic motion of atoms, ions,
molecules, and other relevant components of the system36, 37. Being able to account for such
motion can shed light onto how molecules are rotating, vibrating, what energy state their
electrons may be at, and to decipher various spectroscopic and thermographic spectrums.
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To fully appreciate the first law, the other two laws and associated properties, a brief
explanation of the state of a system, state functions and properties is required. A state system
exists when all necessary variables to describe the system are defined37. The number and type of
variables required to define a system will be system dependent, but in classical thermodynamic
discussions typically are defined by P, V, T and n, representing pressure, volume, temperature
and number of moles of a substance, respectively. A state function, on the other hand, describes
the state of a system, and its properties depend only upon its current state, not how it got there;
thus, a state function is path independent37. Finally, the thermodynamic properties and variables
generally follow under two general categories, intensive and extensive properties. Intensive
properties depend only on magnitude and are independent of quantity (i.e. temperature, pressure,
density, etc.). Extensive properties do depend on amount (i.e. mass, volume).
For the first law it is observed that energy of a system is dependent on heat and work, two
non-state path dependent parameters. However, if a system is allowed to infinitesimally change
so that any change occurs under equilibrium conditions, the process can be considered reversible.
Under such circumstances Q and W are represented as dq and dw, respectively.
While heat transfer and work are what determine the internal energy of a system, it is
generally more convenient to measure other properties such as pressure, volume, and
temperature. Taking an exact differential of internal energy ΔE of equation 1.1 as a function of
temperature (T) and volume (V), we can establish the following relationship.
𝜕𝐸

𝜕𝐸

∆𝐸 = 𝑑𝑞 + 𝑑𝑤 = (𝜕𝑇 )𝑉 𝑑𝑇 + (𝜕𝑉) 𝑇 (1.2)
Under the first law, equation (1.1), it should be noted that specific conditions can create
unique relationships between energy interconversions. For example, under constant heat
(adiabatic conditions) dq goes to zero and changes in internal energy are equivalent to work done
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by/to the system on its surroundings i.e. dE=dw. For constant temperature and constant volume,
change in heat is equivalent to change in work done by the system (dq=-dw).
Under ideal gas conditions, work is defined as pressure (P) multiplied by surface area and
change in height or volume (ΔV). 𝑊 = −𝑃 ∗ ∆𝑉 = −𝑃(𝑉2 − 𝑉1 ). Under reversible conditions
where pressure increases by an infinitesimal amount, maximum work can be defined as
illustrated by equation 1.3
𝑉

𝑉

𝑉 𝑑𝑉

1

1 𝑉

𝑊 = ∫𝑉 2 𝑑𝑤 = − ∫𝑉 2 𝑃𝑑𝑣 = −𝑛𝑅𝑇 ∫𝑉 2
1

𝑉

= −𝑛𝑅𝑇𝑙𝑛(𝑉2 ) (1.3)
1

Alternatively, equation 3 can be expressed in terms of pressure due to Boyle’s law V2/V1=P1/P2
leading to equation 1.4
𝑃

𝑊 = −𝑛𝑅𝑇𝑙𝑛(𝑃1 ) (1.4)
2

In the case of constant volume, change in energy is equivalent to change in heat, as can be
𝜕𝐸

deduced from equation 1.2. Under such conditions, equation 2 can reduce to 𝑑𝑞𝑣 = (𝜕𝑇 )𝑉 𝑑𝑇
and can be expressed as the molar heat capacity at constant volume as:
𝐶𝑉 =

𝑑𝑞𝑣
𝑑𝑇

(1.5)

Molar heat capacity relates heat transferred during a change of state at constant volume.
We can explore the same relationship under constant pressure. Under such conditions, 𝑊 =
−𝑃∆𝑉 = −𝑃(𝑉2 − 𝑉1 ). Under these circumstances, the first law can be expressed by equation
1.6:
∆𝐸 = 𝑄𝑃 = −𝑃(𝑉2 − 𝑉1 ) (1.6)
Where heat is absorbed under constant pressure. Rearranging equation 1.6 leads to equation 1.7
and an important new term, enthalpy.
𝑄𝑝 = (𝐸2 + 𝑃𝑉2 ) − (𝐸1 + 𝑃𝑉1 ) (1.7)
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Enthalpy, H, encompasses the term 𝐸 + 𝑃𝑉 = 𝐻. An increase in enthalpy is equivalent to heat
absorbed by the system at constant pressure and the amount of heat needed to increase internal
energy sufficiently to perform work of expansion by the system37 as shown in the following
equation:
∆𝐻 = ∆𝐸 + 𝑃∆𝑉 (1.8)
Enthalpy is a factor of state functions and as such is a state function as well. Taking the
differential with respect to pressure and temperature yield the following relationship (equation
1.9):
𝜕𝐻

𝜕𝐻

𝑑𝐻 = ( 𝜕𝑇 )𝑃 𝑑𝑇 + ( 𝜕𝑃 ) 𝑇 𝑑𝑃 (1.9)
Since pressure is held constant, the second right hand term disappears, leaving the change in
enthalpy with respect to temperature at constant pressure term. Because 𝑑𝑞𝑝 = 𝑑𝐻 at constant
pressure, we can define the molar heat capacity CP as stated in equation 1.10:
𝐶𝑃 ≡

𝑑𝑞𝑝
𝑑𝑇

𝜕𝐻

= ( 𝜕𝑇 )𝑃 (1.10)

For a change in enthalpy between products and reactants, or change between folded vs unfolded,
Kirchhoff’s equation may be used (equation 1.11):
∆𝐶𝑃 = [

𝜕(∆𝐻)
𝜕𝑇

]𝑃 (1.11)

ΔCP is perhaps the most abstract of the commonly quantitated thermodynamic properties, yet it is
one of the most informative quantities. ΔCP through its shape and sign can indicate polar, or
polar solvation, measure solvation effects, and illustrates the temperature dependence of entropy,
enthalpy, and free energy on a system38; moreover, for the unfolding of a peptide/protein it
represents the change in heat capacity between native and unfolded states39-43 and correlates
strongly with exposed surface area44.
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1.8 The Second Law of Thermodynamics
The second law of thermodynamics provides an explanation of why natural phenomena
generally proceed only in one direction. The reason arises from the Carnot derived system
property, entropy. From the second law as it will be shown, states that the entropy of the
universe always increases. The result is that any natural phenomenon is highly unlikely to
spontaneously reverse conditions back to the preceding state. This is typically proven in two
ways: One, using a theoretical steam engine under reversible and non-reversible conditions; two,
using the Boltzmann distribution equation in a statistical mechanical approach.
For the first method, engine efficiency is defined as work done divided by heat
transferred (Efficiency=W/Q). We can see that engine efficiency will improve with greater
temperature differential between a hot engine and its cold sink. This is expressed
mathematically in equation 1.12:
𝑊
𝑄𝑐𝑜𝑙𝑑

=

𝑄𝐻𝑜𝑡 −𝑄𝐶𝑜𝑙𝑑
𝑄𝐻𝑜𝑡

=

𝑇𝐻𝑜𝑡 −𝑇𝐶𝑜𝑙𝑑
𝑇𝐻𝑜𝑡

= 𝐸𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑐𝑦 (1.12)

If TCold were to approach absolute zero, W/Q=1 and maximum efficiency would be achieved.
If such a perfect engine operated under reversible conditions, then summing hot and cold heat
over THot would result in zero over an engine cycle (see equation 1.13):
𝑄𝐻𝑜𝑡
𝑇𝐻𝑜𝑡

+

𝑄𝐶𝑜𝑙𝑑
𝑇𝐻𝑜𝑡

= 0 (1.13)

As discussed earlier, heat is a path dependent variable; however, when divided by a state
function such as temperature, a new path independent property is created, termed entropy. It can
be expressed in terms of heat, or enthalpy (for infinitesimal changes) in equations 1.14 and 1.15,
respectively.
∆𝑆 =

𝑄𝐻𝑜𝑡
𝑇

(1.14)
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𝜕𝐻

𝑑𝐻 = ( 𝜕𝑇 )𝑃 𝑑𝑇 (1.15)
QHot/THot and QCold/THot are termed the entropy change at hot and cold, respectively, for
reversible processes. Under such conditions, a cyclic process will result in a ΔS=0. The
significance means whatever entropy gained/lost in the system will be matched equally and
oppositely by the surrounding environment and entropy of the universe remains unchanged.
However, for an irreversible process this is not so, and universal entropy increases according to
equation 1.16
∆𝑆𝑈𝑛𝑖𝑣 = ∆𝑆𝑆𝑦𝑠𝑡 + ∆𝑆𝑆𝑢𝑟𝑟 ≥ 0 (1.16)
Alternatively, a statistical mechanical approach using Boltzmann distribution can be used to
describe entropy. Entropy by Boltzmann distribution is defined by equation 1.17:
𝑆 = 𝑘𝑙𝑛(Ω) (1.17)
Where Ω represents the number of microstates, or configurations a system might adopt. Change
in entropy is then defined by equation 1.18:
Ω

Δ𝑆 = 𝑆2 − 𝑆1 = 𝑘𝑙𝑛(Ω2) (1.18)
1

1.9 Third Law of Thermodynamics
The third law of thermodynamics states that the entropy of a pure crystalline substance is
zero at absolute zero, due to this condition being the most orderly configuration possible36.
Entropy can be calculated at any temperature and may be calculated by the following relation
(equation 19):
𝑆𝑇 = ∑

𝑑𝑞𝑟𝑒𝑣,𝑖
𝑇𝑖

+ 𝑆0 (1.19)

Where S0 is the entropy at absolute zero and ST the absolute molar heat at any temperature.
Additionally, dqrev,i under constant pressure conditions can be replaced with CP dT, meaning ST
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values may be obtained from heat capacity and enthalpy changes during phase changes as the
temperature increases36. This is evident from the equation 20:
𝑇 𝐶𝑃 𝑑𝑇

𝑆𝑇 = ∫0 𝑚

𝑇

+

∆𝐻𝑚
𝑇𝑚

𝑇 𝐶𝑃 𝑑𝑇

+ ∫𝑇 𝑉
𝑚

𝑇

+

∆𝐻𝑣
𝑇𝑣

𝑇 𝐶𝑃 𝑑𝑇

+ ∫𝑇

𝑣

𝑇

(1.20)

The third law makes it possible to calculate absolute entropy of a pure substance as evidenced
from the preceding equations.
1.10 Free Energy Applications
An ability to determine if a reaction will proceed spontaneously is critical for biologic
stability assessment. In thermodynamic considerations, predicting spontaneity requires
knowledge of system and surrounding entropy. However, it is desirable to have a parameter
dependent only on the system. To do this, consider equation 15 where change in entropy of an
isolated system is greater than or equal to zero, providing the relationship ∆𝑆𝑆𝑢𝑟𝑟 = −𝑄𝑟𝑒𝑣 /𝑇.
Replacing entropy and heat terms with S and Q, respectively, and rearrangement of the equation,
the following relationship is presented in equation 1.21:
𝑄 − 𝑇∆𝑆 ≥ 0 (1.21)
For a process at constant pressure, a frequent condition of most benchtop experiments and
biologic formulations, we can establish the following relationship by replacing heat Q, with ΔH
and combining first and second law conditions as illustrated by equation (1.22):
∆𝐻 − 𝑇∆𝑆 ≤ 0 (1.22)
Where the left-hand side of equation is termed the Gibbs free energy and expressed as
𝐺 = 𝐻 − 𝑇𝑆 (1.23)
Gibbs free energy, G, is a new state function, because it is based off state properties H, T, and S.
Under non-equilibrium conditions
ΔG=ΔH-TΔS (1.24)
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When ΔG=0 no net work can be gained from the system and has reached equilibrium. However,
when ΔG≤0 then the reaction will proceed spontaneously, while the opposite is true when ΔG≥0
and the reaction will only proceed if energy is added to the system. What drives whether change
in free energy is negative or positive and will proceed spontaneously or not, depends on change
in sign and magnitude of enthalpy, entropy, and temperature. For example, at room temperature,
ice will spontaneously melt despite its large heat of absorption due to the greater effect of
entropy at that temperature.
1.11 Chemical Potential and Activity Coefficients
Thermodynamic principles have been discussed while examining behavior of pure
substances and a single phase; however, this is rarely the case for systems of interest. For
biologic formulations there are at a minimum three components (solvent, biologic, cosolvent)
and potentially multiple phases. This will impact their stabilization and will be discussed in
detail in later sections. For now, consider the free energy of an open, two component system
under constant pressure and temperature as described by equation 1.25:
𝜕𝐺

𝑑𝐺 = (𝜕𝑇 )𝑃,𝑛1,𝑛2 𝑑𝑇 + (𝜕𝑃)

𝜕𝐺

𝑃,𝑛1,𝑛2 𝑑𝑃

) + 𝜇1 𝑑𝑛1 + 𝜇2 𝑑𝑛2 (1.25)

Where the partial derivatives (∂G/∂n1)T and (∂G/∂n2)T are defined as the chemical potential μ1
and μ2, respectively. Using the Maxwell relationships (∂G/∂P)T=V and (∂G/∂T)P=-S, equation
1.25 is re-written as
∆𝐺 = −𝑆𝑑𝑇 + 𝑉𝑑𝑃 + 𝜇1 𝑑𝑛1 + 𝜇2 𝑑𝑛2 + ⋯ (1.26)
Chemical potential, or partial molar volume, under constant pressure and temperature,
components (nj) held constant, the chemical potential of component i is proportional to the
change in free energy due to infinitesimal changes in the number of moles ni as described by
equation 27:
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𝜕𝐺

𝜇𝑖 = (𝜕𝑛 ) 𝑇,𝑃,𝑛𝑗 (1.27)
𝑖

At constant pressure and temperature, the first two right hand terms of equation 25 disappear,
and free energy change is solely dependent on change in molar concentration of components nj
as shown in the expanded and integrated equation 1.25 resulting in equation 1.28:
𝑑𝐺𝑇,𝑃,𝑁 = 𝜇1 𝑛1 + 𝜇2 𝑛2 + ⋯ (1.28)
Chemical potential and its departure from ideal behavior can be described by activity
coefficients. If we consider the vapor pressure of a pure substance above its respective pure
liquid form, its chemical pressure can be described by equation 1.29:
𝜇 = 𝜇 𝑜 + 𝑅𝑇 ln 𝑃 (1.29)
Where μo is the standard, or reference state chemical potential. Using Raoult’s law, P can be
replaced with X (partial pressure of solvent) yielding the following relationship:
𝜇 = 𝜇 𝑜 + 𝑅𝑇𝑙𝑛 𝑋 (1.30)
Departures from ideal behavior are described by the “activity” of the solvent to replace the mole
fraction36 and labeled a. Here a=ϒX, where ϒ is the activity coefficient and can be used to
modify equation 3.28, 3.29, and 3.30 to derive the following relationships illustrated equations
1.31 and 1.32:
𝜇 = 𝜇 𝑜 + 𝑅𝑇𝑙𝑛 𝑎 (1.31)
𝜇 = 𝜇 𝑜 + 𝑅𝑇𝑙𝑛 𝛾𝑋 (1.32)
1.12 Equilibrium Constant and van’t Hoff Equation
The conformation of biologic substances is capable of folding/unfolding, often in
multiple ways. As previously stated, the energy to do so is minimal. To understand the amount
of unfolded vs folded states, we must establish a relationship between free energy and
equilibrium.
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If we consider a model equation 𝑎𝐴 +

𝑏𝐵←→ 𝑐𝐶

+ 𝑑𝐶 where the left and right-hand sides

represent reactants and products, respectively, and define the change in free energy in terms of
chemical potential, the following relationship can be defined as follows:
∆𝐺 = (𝑐𝜇𝐶 + 𝑑𝜇𝐷 ) − (𝑎𝜇𝐴 + 𝑏𝜇𝐵 ) (1.33)
Which we can then substitute in equation 3.29 into 3.31 and rearrange the equation to give an
equation to relate chemical potential to activity
𝑎𝑐 𝑎𝑑

∆𝐺 = ∆𝐺 𝑜 + 𝑅𝑇𝑙𝑛[𝑎𝐶𝑎 𝑎𝐷𝑏 ] (1.34)
𝐴 𝐵

Here, the natural log of the activity of the products/reactants can be represented K. Under
constant pressure and temperature conditions, when change in free energy is zero (i.e. at
equilibrium) equation 3.34 becomes equation 1.35:
∆𝐺 𝑜 = −𝑅𝑇𝑙𝑛𝐾 (1.35)
Equation 1.35 relates the standard free energy change to the equilibrium constant K, allowing the
calculation of standard free energy or K if one of the two is known. This is significant as we
shall soon see, as the conformational free energy change from either folding/unfolding, or
equilibrium constant can be readily determined from analysis of experimental data. Moreover,
from further observation, equation 1.35 and 1.22 can be combined, meaning that at any
temperature the equilibrium constant K (of any appropriate observable) can be used to determine
free energy, enthalpy, and entropy changes of any sort of reaction in a properly defined system.
This, as we shall see, has major implications in the analysis of protein stabilization.
Rearrangement of equation 1.35 makes obvious the relationship of equilibrium constant and
temperature that can be rearranged as follows:
𝑙𝑛𝐾 =

∆𝐺 𝑜
𝑅𝑇

(1.35)

If we differentiate with respect to temperature, equation 1.35 becomes
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𝑑𝑙𝑛𝐾
𝑑𝑇

1

= 𝑅∗(

∆𝐺𝑜
)
𝑑(
𝑇

𝑑𝑇

) (1.36)

The Gibbs-Helmholtz equation relates the change in free energy with respect to temperature and
may be combined with equation 3.36 to give the familiar van’t Hoff equation37 1.37:
𝑑𝑙𝑛𝑘
𝑑𝑇

=

∆𝐻 𝑜
𝑅𝑇 2

(1.37)

Where ΔHo is the standard enthalpy of reaction. This relationship may be combined with
equation 1.37 and 1.22 to yield another useful relationship that shall be exploited in
understanding protein stability in equation 1.38:
∆𝐻 𝑜

𝑙𝑛𝐾 = − ( 𝑅𝑇 ) + ∆𝑆 𝑜 /𝑅 (1.38)
In equation 1.38, ΔSo/R is the intercept of the line lnK of the plot of lnK over 1/T.
1.13 Peptide/Protein Stabilization Principles (Liquid State)
Proteins and peptides are stabilized through thermodynamic properties. Building from
equation 1.33, the free energy change from native to denatured is quantitated from the following
relationship.
∆𝐺 = 𝐺 𝐷 − 𝐺 𝑁 𝐷 = −𝑅𝑇𝑙𝑛𝐾 = −𝑅𝑇𝑙𝑛[𝐷]/[𝑁] (1.39)
where D is the concentration of the denatured structure, N, native concentration. A driving force
behind folding is the hydrophobic effect 25, 45. Water, accumulating around hydrophobic side
chains and patches, orders itself reducing the overall entropy of the system, leading to the folding
and burying of hydrophobic side chains, while exposing the more hydrophilic amino acid
backbones. Indeed, folding of proteins is relatively tight, with Pace and associates reporting
radius of gyration (Rg) for model proteins as approximately 0.75 angstroms. For reference, Rg of
water, ethanol, and closed pack spheres are 0.35, 0.47, and 0.71 angstroms, respectively 25.
Additionally, the same authors demonstrated that the larger the protein, the higher percentage of
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residues were folded . Earlier work by Pace and others demonstrated burial of -CH2- groups
contributed 1.2 kcal mol-1 per ang3 and through other models estimated the hydrophobicity
contributes 80% to the hydrophobic effect 25. Other important contributions are those of
hydrogen bonding and van der Waals interaction with polar groups 25.
1.14 Mechanism of Protection Through Direct Ligand Interaction (Wyman Linkage)
As can be seen from equation 1.1, free energy of native vs denatured states is critical to
protein stability, with solvent, co-solvent and various additives, all potentially altering the
equilibrium of the species. Stabilization occurs through two general categories: one, increased
stability of the native state through Wyman type linkage; two, increased free energy potential for
the denatured state. For the former, an endogenous ligand or stabilizing metal ion, buffer, etc.,
can increase stabilization of the native state (see Figure 1.3) 26, 46, 47.

Figure 1.3. Wyman linkage stabilization of protein. 3
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For the latter, preferential exclusion, increased hydration through osmolytes is the
mechanism of action and an explanation will be given presently. Alternatively, the reverse can
also be true; binding of an excipient to protein can stabilize the unfolded state.
1.15 Mechanism of Protection (Preferential Exclusion)
Osmolytes in nature (at the cellular level) and in biologic formulations are typically
found in the hundreds of mM range 8, 35, 46-49. In these concentration ranges osmolyte compounds
act as co-solvent and can associate around the protein surface at concentrations similar to, lower
and higher than that of the bulk solution and described as the interaction parameter 6, 7, 35, 46, 47, 4951

in equation 1.40:
𝜉3 = 𝜕3 /𝜕2 = 𝐴3− 𝑔3 𝐴1 (1.40)

Here, gi is the concentration of component i in grams per gram of water and Ai is the amount of
component i interacting with protein in grams per gram, the numbers 1, 2, 3 refer to water,
protein, and osmolyte, respectively. Changes in the composition of the solution around the
protein relative to the bulk solvent changes the activity coefficient of water, giving rise to
changes in osmotic pressure across the surface area of the protein. The consequence being a
change in the free energy of the native vs denatured states from our thermodynamic discussion
given, a free energy relationship can be surmised in equation 1.41:
𝑘

𝐷)
𝐷)
−𝑅𝑇𝑙𝑛 (𝑘 ) = (𝐺 𝐷 − 𝐺𝑊
− (𝐺 𝑁 − 𝐺𝑊
= ∆𝜇2𝐷 − ∆𝜇2𝑁 (1.41)
𝑤

Which describes the free energy transfer of the denatured and native protein and can be related to
the interaction parameter through the following relationship (equation 1.42).
𝑀

𝜕𝑚

(𝑀2 ) (𝜕𝑔3 /𝜕𝑔2 ) = (𝜕𝑚3 ) 1.42
3

2

(𝜕𝜇2 /𝜕𝜇3 ) = −(𝜕𝑚3 /𝜕𝑚2 )(𝜕𝜇3 /𝜕𝑚3 ) 1.43
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Where Mi is the molecular weight of component i, mi is the molality of the i component. This
means the interaction parameter (𝜕𝑚3 /𝑚𝜕2 ) if negative, increases the energy of the protein; if
positive free energy decreases46. The transfer free energy can be obtained through integration of
(𝜕𝜇3 /𝜕𝑚3 ) to yield equation 1.44:
∆𝜇2 = ∫(𝜕𝜇2 𝜕𝑚3 )𝑑𝑚3 (1.44)
If the co-solvent is excluded to a greater degree from the denatured state (i.e. (𝜕𝑚3 /
𝑚𝜕2 ) 𝐷 < (𝜕𝑚3 /𝑚𝜕2 ) 𝑁 < 0 then (𝜕𝜇2 /𝜕𝑚3 ) 𝐷 > (𝜕𝜇2 /𝑚3 ) 𝑁 ), the protein will be
stabilized by the co-solvent because the resultant transfer free energy of the denatured
conformation will exceed the native conformation. The compounds that preferentially bind to
protein (left) and those that are excluded have on the hydration shell of a protein, as shown in
Figure 1.3. The effects on conformation and stability are shown in Figures 1.2.

Figure 1.3. Preferential binding/exclusion by solutes. 4
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An unfolded protein will have a greater surface area than the folded, native version of the
protein. Cosolvents, which are preferentially excluded from a protein surface, create an
enhanced hydration shell around said protein, increasing surface tension and osmotic pressure
than it would experience in their absence. This increased pressure causes a protein to adopt a
compact/native structure to minimize surface area and overall osmotic pressure. Denaturants
have the opposite effect; they can bind to protein surfaces, reduce the hydration shell, and can
decrease the ordering of water around protein and promote unfolding 46, 52, 53,
There are exceptions to these rules. Polyethylene glycol is an excellent osmotic, strongly
excluded from the surface of proteins, but can have destabilizing effects on protein
conformations in the liquid state 51. While PEG is excluded from the surface, it has hydrophobic
regions that can stabilize hydrophobic regions on a protein and reduce the energy difference
between the native and denatured conformation. Indeed, PEG can lower the Tm of proteins 51,
but can have other stabilizing and desirable factors as well.
1.16 Excluded Volume
It is well known that cellular environments are exceptionally crowded14, 16, 35, 54, 55, and
this crowding effect impacts both form and function of the local protein and peptide denizens14,
16, 49, 54, 56, 57

. Unlike osmolytes and other preferential exclusion excipients, which have negative

interaction with a proteins surface and stabilize native conformations enthalpically16, 49, 56,
crowders have minimal interaction with protein. Molecular crowders, as the name implies,
occupy significant portions of the limited volume in a system, inhibiting peptide/protein
unfolding of native structures, as the larger denature state would experience greater entropic loss
than compact native structures14, 16, 56, 57. (Figure 1.4).
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Figure 1.4. Effects of crowding agents on free energy of peptide/protein unfolding. 5

As can be seen from Figure 1.4, free energy of unfolding increases due to decreased
volume available for the expanded molecule to move, reducing its entropic component.
Molecular crowders such as dextran and other polymeric excluders typically demonstrated
stabilization through increased Tm with minimal enthalpic change14, 16, 54 observed. Here,
entropic forces dominate stabilization16 and a decrease in entropy tracks with crowder
concentration. As might be expected, crowder size often matters, as two molecules at minimum
occupy the sum of their radii implying a larger crowder is often a more efficient excluder (Figure
1.5). In Figure 1.5, RP and Re are the protein and excipient radii, respectively, and the shaded
gray area is the hydrated portion of the protein.
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Figure 1.5. Visualization of crowder size and exclusion effect. 6

Crowding agents may, of course, also interact favorably or poorly with a protein surface
and may alter the solvent surrounding the biologic agent in a kosmotropic/chaotropic fashion.
Such behavior would impart preferential exclusion/interaction properties to an excipient and may
thus enhance or reduce the stabilizing behavior of the cosolute. Polyethylene glycols are known
to sometimes behave in such a way; however, it is often protein specific when doing so.
1.17 Interfacial Protection
As mentioned, another primary conformational destabilization pathway is that of
absorption. Biologics can be exposed to various hydrophobic surfaces such as air, glass, silicon
oil, etc. Mechanical stresses such as vibrations while transporting, shaking/vortexing to
reconstitute a lipolyzed biologic can increase the amount of protein exposed to air/liquid
interface. Contacting such surfaces decreases the free energy between folded/unfolded species,
increasing the probability of denaturation. To combat these issues, surfactants are employed to
reduce biologic/interface exposure. While myriad surfactants are commercially available, they
are generally composed of the same elements, namely a hydrophilic head, aliphatic tail, and are
amphipathic in nature. Like all stabilizing excipients, surfactants can have complicated and
varying effects on protein stability, solubility, viscosity, aggregation propensity and so forth
depending on the protein/peptide to stabilize and amount and type of surfactant used 8, 13, 28, 34, 35,
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46, 58-62

. The most common surfactants employed are polysorbate 20, polysorbate 80 (tween 20

and 80 respectively) and Poloxamer 188.
There are two primary protection mechanisms provided by surfactants: One,
displacement from and preferential absorption to hydrophobic surfaces; two, favorable
interaction with the protein’s native conformation, or temporary binding and stabilization of
unfolded regions until displacement of surfactant and refolding occurred 13, 59-61.
The former mechanism, displacement, is a function of concentration. Depending on
concentration, surfactants have varying effects on a solution (see Figure 1.6). At low
concentration, surfactants absorb to any available surface, displacing higher energy solution
components, reducing the interfacial surface energy of the system (see region 1). As the
surfactant concentration increase, surfactants will populate air, container, protein, and other
surfaces to a greater degree, reducing the surface tension of water in a concentration dependent
manner (region 2). As surfactant concentration increases, surface tension remains constant as
much of the air/water sites are occupied, but due to thermodynamic considerations, continues to
bind to the protein (region 3). If surfactant is increased further, it will begin to displace protein
from the surface, reducing the surface tension, which again will plateau (region 4). Addition of
more surfactant will result in complete displacement of protein and form micelles (region 5)28.
Interfacial protection is critical, given the likelihood of protein exposure to these
hydrophobic surfaces. Often proteins will be exposed to various mechanical stresses, oils, and of
course air; therefore, protection is critical8, 9, 26, 63. PS 80 has shown to be a more potent displacer
and better absorber of proteins than PS 20 or PXO 188; however, the latter is somewhat less
likely to degrade into toxic, or denaturant material9, 26, 63.
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Figure 1.6. Effect of surfactant concentration on surface tension28. 7

Interfacial protection is critical given the likelihood of protein exposure to these
hydrophobic surfaces. Often proteins will be exposed to various mechanical stresses, oils and of
course, air; therefore, protection is critical9.
Surfactants can favorably interact with protein surfaces 13, 28, 34, 61, 62, though often in a
much more attenuated manner than charged polymers such as SDS9. For example, Hoffman and
company demonstrated tween 20 and 80 binding to BSA, mild interaction with lysosome and no
binding with IgG1, while Chou through ITC demonstrated albutropin had a 10:1 binding ratio of
surfactant to protein and moderate binding affinity relative to ionic polymers 60. Similarly, Bam
and Tandor demonstrated the ability of surfactants to stabilize partially unfolded peptides by
preventing aggregation, and help in refolding 59, 61. In a partial explanation of this behavior, a
recent study by Arisoco through MD simulations demonstrated the ability of tween 20 to bind to
unfolded portions of rHGH with the hydrophilic heads orientated towards the hydrophobic
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patches of the protein. It was postulated that these interactions occupied sites prone to
aggregation, yet through unfavorable interaction encouraged refolding64.
1.18 Colloidal Stability, Solubility and Viscosity
Given the size and chemical make-up of proteins, they may possess various charges and
dipoles potentially causing attractive/repulsive interactions between molecules. Such
interactions can affect solubility, viscosity, and aggregation of a biologic therapeutic.
Colloidal stability results from the balancing of the various protein charges resulting in
solution, thus reducing risk of aggregation, and optimizing the competing properties of solubility
and viscosity. Colloidal stabilizing excipients function via screening protein charges, or similar
to surfactants, occupy hydrophobic interactions of the proteins33, 65, reducing aggregation
potential.
Enhancing conformational stability through use of osmolytes is often done; however,
stabilization through such compounds can decrease solubility and increase viscosity. Briefly,
solubility is governed by the thermodynamics of the protein solution (i.e. transfer free energy in
this case from solid to liquid), as well as the activity and ionic strength of the solution 7. For
example, denaturants and other conformational destabilizers can lower the surface transfer free
energy of the protein relative to pure water and improve solubility. Electrolytes can improve
solubility via suppression of electrostatic interaction at appropriate concentrations but reduce
solubility due to specific protein-ion interactions (salting out) when concentrations become too
high52, 53, 66.
Viscosity, like solubility, is often another casualty when seeking conformational stability,
especially at high concentrations desired in many formulations. It depends on several factors,
some long range and some short range forces, the importance of which will change depending on
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the nature of the protein and co-solvent. Overall solution characteristics are often determined by
electrostatic repulsions as these are long range effects 66. As protein and excipient
concentrations increase, so do excluded volume, van der Walls, hydrophobic (protein-protein
interaction), charge-charge and other electrostatic effects. Figure 1.7 illustrates some of these
interactions; namely, volume exclusion, electrostatic repulsion/attraction, and hydrophobic
attraction. Use of various excipients for screening the latter three will be detailed, and from
previous discussion on stability it can be seen highly excluded stabilizing agents will limit
solubility66.

Figure 1.7. Effect of different interaction parameters on viscosity. Modified from Current
Protein & Peptide Science 2018, 19 (8), 746-758. 8
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Several viscosity models have been purposed for various situations. When considering
the volume exclusion effect only, the Einstein equation and derivatives are widely used, the
general formula described by equation 1.45:
𝜂 = 𝜂0 (1 + 2.5𝜙) (1.45)
Where η, η0 and φ represent the solution viscosity, the water viscosity, and volume
fraction of the solute. The value 2.5 is a parameter for solid sphere and is a function of solute
shape. As can be seen, increasing the solute concentration will increase viscosity independent of
specific interaction.
Deviation from this behavior at high protein concentrations is observed. Many empirical
derivates of the Einstein equation can be found in the literature, with two being discussed here by
Kreiger-Doughter and Conley equations, 1.46 and 1.47, respectively.
𝜙

𝜂 = 𝜂0 exp (1 − 𝜙 )−[𝜂]𝜙𝑚 (1.46)
𝑚

𝜂 = 𝜂0 exp (𝜅𝐶) (1.47)
Where φ is the volume fraction of the protein, φm is the maximum volume fraction molecule, κ
and C are a constant and protein concentration respectively 66.
It is obvious from these two equations and others like them, that protein viscosity does
not increase linearly with concentration, rather it follows an exponential behavior. The two
previously mentioned equations fit BSA, globular proteins and antibodies fairly well. The
Conley equation, while simple, does show deviations for antibodies at concentrations exceeding
300 ng/ml 66.
Proteins, being large, have multiple and variably charged compounds, and the viscosity
effects are not solely determined by exclusion effects. Electrostatic interactions play significant
roles as well in the form of repulsion or attraction. For dominant repulsion forces, maintaining a

47
pH near the isoelectric point (pI) will reduce such charge interactions as the molecule will be in
its most neutral form, lowering viscosity. Additionally, a low concentration of salt will shelter
such repulsions. Higher concentrations may increase exclusion effects especially with
chaotropic ions typically employed in formulation. For electrostatic attraction, the opposite
principle applies; moving away from the pI will decrease solubility.
An additional factor to consider is hydrophobic and clustering potential of proteins and
their effect on viscosity. As discussed earlier, protein association brings risk of aggregation and
more distressingly, irreversible aggregation. Arginine and amino acids with aromatic side chains
and substances are often used here to reduce viscosity and risk of aggregation. Arginine and
similar molecules can interact weakly with aromatic and hydrophobic sections, buffering these
portions of the protein from associating with other proteins, preventing an increase in viscosity,
and reducing the risk of aggregation.
1.19 Chemical Stabilization (Liquid Phase)
Chemical instability of proteins tracks strongly with amino acid sequence with
degradation of product occurring via some form of hydrolysis or oxidation8, 9, 18, 67; and chemical
degradation can have a significant effect on physical conformation and aggregation propensity68.
Excipients such as buffers, osmolytes and surfactants can greatly mitigate degradation. For
example, at low pH, the rate of deamination and other hydrolysis routes are greatly enhanced8, 67,
68

. Aside from the use of proper buffers and concentration (type and amount are critical67) to

mitigate degradation, osmolytes can stabilize native conformation, limiting movement, slowing
hydrolysis. This has been observed in different antibodies when replacing NaCl with trehalose
or mannitol, which reduced chemical degradation and enhanced overall stability while under
storage at 25 and 40oC67. Wang and the coworkers observed increased deamidation of 1gG1
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antibodies formulated with phosphate buffers relative to citrate buffers . While no mechanism
was proposed, Zbacnik noted PBS and citrate buffers enhanced conformational stability in a
concentration dependent manner, and suggested it proceeded through a Wymann ligand binding
mechanism26. Indeed, many proteins are affected differentially by phosphate vs citrate buffer. If
preferential binding stabilization is a factor, then it would not be surprising they would impart
varying protection based on protein composition.
1.20 Solid Phase Stabilization
While focus of this work will deal with stabilization of biologics in liquid formulations,
many compounds undergo lyophilization formulation, as it greatly enhances product shelf-life
and eliminates the cold-chain requirement. However, lyophilized compounds will have to be
reconstituted and be stable in the liquid form. Moreover, many of the same excipients utilized in
liquid formulations are found in lyophilized products but may vary in their function relative to
the enumerated mechanisms for the liquid state.
Briefly, lyophilization is composed of three steps: Freezing, primary drying then
secondary drying. During the freezing step, water molecules freeze first, increasing the protein
concentration and viscosity of the solution, inhibiting further crystallization. As the temperature
continues to decrease, the remaining solution will harden to an amorphous, crystalline, or
combined amorphous/crystalline solid (see Figure 1.8). Primary drying removes the water and is
performed at a temperature below the collapse temperature also referred to as the glass transition
temperature T’g, or Teut (eutectic point) for amorphous or crystalline compounds, respectively.
Below this temperature, the compound will remain in a glassy, solid state27, 31. Further
dehydration (secondary dehydration) is carried out at a higher temperature to increase the rate of
water removal.
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Figure 1.8. Effect of solute concentration on physical state of protein/biologic formulation.9

Lyophilization exposes delicate compounds to two new stresses, freezing and
dehydration. As the formulation freezes, ice-water interfaces are created that can cause
absorption and denaturation of proteins, leading to potential loss of activity, aggregation, and
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precipitation. Sublimation removes water, resulting in a loss of hydrogen bonds between the
residues and structures in protein, another potentially denaturing factor 20, 46, 69.
Much like liquid formulations, excipients are utilized to stabilize lyophilized
formulations and are purported to do so by two main mechanisms: vitrification and water
replacement. According to vitrification, excipients stabilize protein through the formation of
glassy state that immobilizes the protein. Water replacement functions through replacement of
water-protein hydrogen bonds with those of a suitable excipient, thereby stabilizing the protein
structure. Several FTIR studies have demonstrated the effectiveness of disaccharides in
maintaining the secondary structure of protein after dehydration 46, 70.
Mobility of protein is often associated with stability and propensity for aggregation 20. It
has been purposed those combined effects of vitrification and water replacement can play a
primary role in protection depending on the protein, type of movement, and conditions of the
formulation at particular temperatures 20, 69. Vitrification is best at protecting when global
movement restriction is the predominant destabilization pathway, while water replacement can
have a dominant effect for local movement 20. Physical degradation may be more affected by
global movements (vitrification), whereas chemical pathways are more likely governed by those
of local motility (water replacement). It is important to remember that although protein glass
transition temperatures are above the freezing temperature of water, it can still have significant
mobility 10-200C below the Tg 20.
Immobilization is the goal for stabilizing lyophilized products. Properly designing such
formulations can be very protein specific, depending greatly on the active ingredient’s
composition and excipient components. While optimization is very often a case by case
endeavor, there are common principles and considerations that can be applied broadly. Chief
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among these concerns are selections of proper cryoprotectants and lyoprotectants.
Cryoprotectants, such as surfactants, protect the product during the freezing process by reduction
in exposure to ice-water interfaces 20, 31, 35. Lyoprotectants, such as disaccharides, protect against
dehydration in the form of water replacement (hydrogen bond with the protein), but also form a
glass state and vitrification protection properties. Tg temperature is another important
consideration and directly related to cyro and lyoprotectant excipients chosen 20, 31. Generally,
the higher the Tg the better; however, many cryoprotectants such as tween 20 and tween 80 are
plasticizers, and will lower the Tg, thus a balance needs to be maintained and evaluated when
selecting type and amount of cryoprotectant. Other considerations include buffer selection
(buffer pH can change drastically such as phosphate buffer; tris and citrate buffers are generally
used), reconstitution times, and bulking agents 30, 31.
1.21 Chemical Degradation (Solid Formulation)
As in the case of liquid formulations, chemical degradation remains an important
consideration, with pH, mobility, and interface interactions playing central roles in degradation
rates. Solid phase formulations, due to the freezing and dehydration phases are especially
important during the processing steps. During freezing, pH can change dramatically as the liquid
phase decreases and concentrates product and excipients. Thus, careful consideration needs to
be given to buffer type as said changes may exceed its protective range10. Other excipients
including sugars, amino acids and various surfactants have been shown to decrease degradation,
presumably from conformation maintenance and buffering capacity67. For the later
consideration, histidine, arginine, and glycine have been proposed to be effective in this role67.
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1.22 Excipient Types, Classification, and Purposes
An excipient is any substance other than the active pharmaceutical ingredient added
during the manufacture or finished product71. Excipients are added for a variety of reasons such
as stabilization, increased solubility, viscosity reduction, pH control and many others. For our
purposes here, excipient classes used in parenteral and lyophilized formulations will be discussed
briefly, in terms of osmolytes, surfactants, and buffers, with a few examples given.
1.23 Molecular Crowders
Some common molecular crowders are dextran’s, PEGs, polyvinylpyrrolidone (PVPs),
Ficoll-70000, and hydroxyethyl (beta) starch and more recently, glycopolymers and
functionalized dextrans72. As previously discussed, they interact minimally with the API, instead
of stabilizing the native confirmation entropically through volume exclusion. However, volume
exclusion may not be the only effect on the compound, as certain crowders may interact with
local regions of a protein in a preferential manner, causing local instability.
1.24 Surfactants
Surfactants serve to protect compounds from interfacial stress in either the liquid or solid
state. During freezing, transportation, reconstitution, or administration, biologics are exposed to
mechanical stress, mixing, cavitation, and denaturizing substances such as oil and glass.
Common surfactants include polysorbate 20 or 80, PLX 188, cyclodextrins, amino acids glycine,
and histidine to name a few. In the liquid phase, they protect by aggregating onto unfolded
portions of the protein surface, at various interfaces and protect protein from aggregation.
During the lyophilization process, interfaces form between ice crystals and the remaining
solution, creating potentially denaturative surfaces. Here surfactants will serve as cryoprotectant
and lyoprotectants, minimizing surface interactions10, 30, 64. Careful consideration needs to be
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given to surfactant selection when preparing a lyophilized formulation. Surfactants generally
will reduce the collapse temperature of the resulting cake and vary in their hydroscopic nature.
Generally, the less surfactant needed, the better.
1.25 Buffers and Salts
One of the most ubiquitous excipients, buffers play an important role in biologic
formulation in liquid or solid state. At the most basic level, they serve to maintain an appropriate
pH for the therapeutic. Mechanisms behind conformational stabilization range the big three:
conformational, colloidal, and interfacial. Given the relatively low concentrations of buffers in
formulations to those of commonly used osmolytes, conformational stability is generally
believed to occur through ligand binding rather than preferential exclusion, though there are
examples of the latter protection mechanism as well26. Additionally, buffers can function as a
surfactant with charged ions accumulating at air or ice interfaces. Colloidal stabilization through
charge screening and hydrophobic blocking is possible too26, 33. An important consideration for
buffer use is temperature. During the lyophilization process, low temperature and dehydration
can greatly change the solution pH, potentially outside a buffer’s protective range; however,
other protective benefits may negate this behavior26. In addition to physical stability, chemical
stability can be enhanced with maintenance of appropriate pH.
Common excipients include phosphate buffer, acetate, and tris buffers (the former two are often
used in lyophilized formulations). Amino acid buffers such as histidine, glycine, and arginine
are also commonly used and are popular in lyophilized products. With regards to amino acid
buffers, arginine performs multiple functions, acting as a buffer, surfactant, and viscosity
reducing agent (the latter is believed to occur through screening of aromatics8).
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Salts can function as charge screeners and osmolytes depending on whether it has salting
in/out characteristics52, 73. As such they can be used to improve solubility, viscosity, or
conformational stability.
1.26 Analytical Method
1.26.1 Thermal Course of Heat Capacity and Enthalpy
Measuring protein/peptide stability is generally considered in thermodynamic terms and
often assessed through monitoring unfolding under thermal, chemical, other stresses. Unfolding
is generally measured using certain assumptions/approximations like two state and reversibility,
or a justification of why such approximations are valid. Additionally, data is generally fit to
specific mathematical models to determine the desired parameters. In this section, a brief
explanation of change in enthalpy determined through change in heat capacity (Kirchhoff’s
relationship) and how it is used to measure thermodynamic changes due to unfolding is
discussed. Ultimately, data from CD, DSC, NMR was fitted using the discussed equations and
models.
Unlike traditional melting temperatures of many substances where a phase transition
occurs at a single temperature, protein unfolding occurs over a temperature range and its
temperature dependence tracks the change in heat capacity (equation 1.48):
𝑇

∆𝐻𝑐𝑎𝑙 (𝑇) = ∫𝑇

𝑖𝑛𝑖

𝐶𝑝,𝑁𝑈 (𝑇)𝑑𝑇 (1.48)

The DSC determined enthalpy ΔHcal (T), incorporates the conformational enthalpy
(ΔHοNU) and the increased heat capacity of the unfolded heat capacity due to increased water
binding to the larger protein surface area42; as shown in the relationship shown below:
0
0
0
∆𝐶𝑝,𝑁𝑈
= 𝐶𝑃,𝑈
− 𝐶𝑃,𝑁
(1.49)
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This increase in heat capacity has direct bearing on the discussion at large, given that excipients
will directly increase the enthalpic cost of an unfolded protein. Therefore, it is important to
account for this increase in heat capacity in a temperature dependent manner as shown in
equations 1.50:
0
0
∆𝐻𝑁𝑈 (𝑇) = ∆𝐻𝑁𝑈
+ ∆𝐶𝑃,𝑁𝑈
(𝑇 − 𝑇𝑚 ) (1.50)

Transition temperature Tm is chosen as reference temperature as it is easily deduced when
ΔG=0, since in this scenario the protein/peptide is half denatured regardless of the number of
steps (equation 1.51). The experimentally determinable enthalpy is determined by multiplying
ΔHNU(T) by the fraction unfolded (ΘU(T)) (equation 1.52). The predicted heat capacity is
determined by taking the derivative of the enthalpy with respect to temperature (equation 1.53)
0
0
∆𝐻𝑁𝑈
= 𝑇𝑚 ∆𝑆𝑁𝑈
(1.51)
0
0
∆𝐻(𝑇) = ∆𝐻𝑁𝑈 (𝑇)𝛩𝑈 (𝑇) = [∆𝐻𝑁𝑈
+ ∆𝐶𝑃,𝑁𝑈
(𝑇 − 𝑇𝑚 )]𝛩𝑈 (𝑇) (1.52)

𝐶𝑃,𝑁𝑈 =

𝑑𝛩𝑈 (𝑇)
𝑑𝑇

0
+ ∆𝐶𝑃,𝑁𝑈
Θ𝑈 𝑑𝑇 (1.53)

The first term on the right side is conformational change contribution, the last the increase in
heat capacity. Thus, the enthalpic contribution from heat capacity is given by equation 1.54:
𝑇

0
0
Δ𝐻𝐶𝑝
= ∫𝑇 𝑒𝑛𝑑 Δ𝐶𝑃,𝑁𝑈
Θ𝑇 𝑑𝑇 (1.54)
𝑖𝑛𝑖

ΘU(T) can be calculated using either a two-state or multi state model.
From the equation 1.35 (Δ𝐺 = −𝑅𝑇𝑙𝑛(𝐾(𝑇)) = Δ𝐻 − 𝑇Δ𝑆) it can be seen ΔG is affected by
temperature protein folding. Accounting for changes in heat capacity, folding entropy can be
determined by equation (1.54)
𝑇

0
0
Δ𝑆𝑁𝑈 (𝑇) = Δ𝑆𝑁𝑈
+ Δ𝐶𝑃,𝑁𝑈
ln (𝑇 ) (1.54)
0
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The predicted free energy can thus be described by equation 1.55 or shortened to equation 1.56
when heat capacity cannot be measured.
𝑇

𝑇

𝑚

𝑚

0
0
0
(𝑇 − 𝑇𝑚 ) − 𝑇Δ𝐶𝑃,𝑁𝑈
Δ𝐺𝑁𝑈 (𝑇) = 𝐻𝑁𝑈
(1 − 𝑇 ) + Δ𝐶𝑃,𝑁𝑈
ln (T ) (1.55)
𝑇

0
Δ𝐺𝑁𝑈 (𝑇) = 𝐻𝑁𝑈
(1 − 𝑇 ) (1.56)
𝑚

Heat capacity is generally not measurable through spectroscopic techniques but can be
determined through tracking the enthalpic change with respect to transition temperature Tm
(equation 1.57).
𝑑Δ𝐻
𝑑Δ𝑇

= Δ𝐶𝑃 (1.57)

1.26.2 Two-State Model
The simplest and most often employed model42, two-state unfolding assumes a protein
adopts only two conformational states, native (N) and unfolded (U). The fraction of N vs U is
determined by temperature dependent equilibrium constant K(T) as seen in equation 1.58, where
[N] and [U] are native and unfolding concentrations, respectively, and equation 1.59 relates
ΘU(T) to equilibrium constant.
𝐾(𝑇) =

𝑈
𝑁

=

Θ𝑈 𝑇
1−Θ𝑈 𝑇

(1.58)

𝐾(𝑇)

Θ𝑈 (𝑇) = 1+𝐾(𝑇) (1.59)
From equations 1.58 and 1.59 the relationship between free energy and equilibrium constant
becomes clear i.e. Δ𝐺 = −𝑅𝑇𝑙𝑛(𝐾(𝑇)).
Likewise, chemical denaturation can be described by relationship given in equation 1.60
𝐾(𝐶𝐷 ) = 𝐶𝑈/ 𝐶𝑁 = Θ𝑈 (𝑇) = 𝐶

𝐶𝑈

𝑈 +𝐶𝑁

𝐾

= 1+𝐾 , 𝑡ℎ𝑒𝑟𝑒𝑓𝑜𝑟𝑒, ΔG𝑁𝑈 𝐶𝐷 = −𝑅𝑇𝑙𝑛𝐾(𝐶𝐷 ) (1.60)

Where CN and CU refer to native and unfolded species concentrations, respectively, and CD the
denaturation concentration.
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Changes in free energy due to chemical denaturation can also be described by equation 1.61
Δ𝐺𝐷 = Δ𝐺𝐷𝐻2𝑂 − 𝑚[𝐷] (1.61)
Where [D] is denaturant concentration and m is the slope and measure of the change in free
energy with changing denaturant concentration and corresponds directly to the amount of protein
solvent exposed surface area74, 75.
1.26.3 Multi-State Folding (Zimm-Bragg theory)
Protein unfolding often occurs in a sequential manner and is inadequately described by a
two-step model. Several ideas have been put forward over the years to account for the multi-step
process of coil-to-helix transition76, 77. One model, Zimm-Bragg (ZB) theory, has demonstrated
utility in describing protein unfolding and thermodynamic parameters in globular proteins with
not only helical content, but varying SS composition 39-42.
For the simplest iterations of the ZB model, unfolding proceeds in a sequential manner
were local equilibria between native “(n)” and “(u)” residues exist. Interactions proceed through
nearest neighbor effect, and heterogeneous residues are averaged enthalpicaly39, 41, 76, 78. The
lowercase is used to delineate between individual residues rather than the whole molecule of a
two-state model. For the original models, “n” refers to helical residue while “u” is a coil amino
acid. For reasons that will be discussed later, “n” and “u” will be used to describe
folded/unfolded, respectively of any SS feature. Though specific backbone interactions govern
SS formation and geometry, i.e. i and i+3 for helices, this is adequately accounted for in ZB
since cooperative changes between adjacent residues leads to the proper torsional angles between
peptides resulting in the defined SS40, 42.
ZB is governed by two parameters, nucleation σ and propagation s. The former describes
the penalty of forming helix-coil junctions in a helical strand and defines the sharpness in
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conformational change near the transition temperature. In most cases it is relatively constant
under various thermal and chemical stresses and is often treated as such. Typical values range
from 10-3-10-6. The propagation factor, on the other hand, is sensitive to both the temperature
and chemical environment and described by equations (1.62 and 1.63) respectively:
𝑠(𝑇) = 𝑒

ℎ
𝑅

1
1
)
𝑇 𝑇𝑚

− ∗( −

(1.62)

𝑆(𝐶𝐷 ) = 𝑒 −𝐾𝐷(𝐶𝐷−𝐶𝑚) 𝑤ℎ𝑒𝑟𝑒 𝑛 + 𝐷 ⇄ 𝑢 𝑎𝑛𝑑

𝐶𝑢
𝐶𝑛

= 𝐾𝐷 𝑐𝐷 (1.63)

Here, h is defined as the enthalpy of unfolding per residue, D the denaturant, KD the
binding constant of the denaturant, Cm the chemical denaturant concentration at the transition
point. σ and s are often determined through fitting data to the defined ZB model, h can be fitted,
or calculated as well, but is often estimated from literature sources and will be discussed in
greater detail shortly.
The mathematical explanation of ZB can be surmised as follows. A polypeptide chain of
length N units can adopt 2N conformations (helix or coil), with combinations of i+1 for a
continuation of a sequence leading to cc, hc, ch, and hh possibilities. The probabilities of all
occurrences can be described by matrix M (see equation 1.64)
1
𝑀=(
1

𝜎𝑠
) (1.64)
𝑠

Where s is given by equation 24, and M can be used to calculate partition function Z (equation
1.65).
1
𝑍(𝜎, 𝑠, 𝑁) = (1 0)(
1

𝜎𝑠 𝑁 1
) ( ) (1.65)
𝜎
1

Taking the derivative of the natural log of Z with respect to temperature fractional helicity at any
temperature can be determined (equation 1.66).
𝑠

Θℎ𝑒𝑙𝑖𝑥 (𝑇) = 𝑁 ∗

𝑑(𝑙𝑛𝑍(𝜎,𝑠,𝑁))
𝑑𝑇

∗ (𝑑𝑠/𝑑𝑇)−1 (1.63)
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Combining equations 1.58 and 1.59 thermodynamic properties of sequential unfolding can be
determined. Free energy of unfolding is governed by propagation factor s(T) or s(CD) for
thermal or chemical denaturation, respectively, and is given by equations 1.64 and 1.65:
)

𝑠(𝑇

0
Δ𝐺𝑁𝑈
= −𝑁𝑅𝑇𝑙𝑛( 𝑠(𝑇𝑒𝑛𝑑) ) (1.64)
𝑖𝑛𝑖

)

𝑠(𝐶

0
Δ𝐺𝑁𝑈
= −𝑁𝑅𝑇𝑙𝑛( 𝑠(𝐶𝑒𝑛𝑑) ) (1.65)
𝑖𝑛𝑖

An additional feature of ZB theory is the probability determination of any conformation. One
feature of interest is that of the number of helices in a sequence, which is described by equation
1.66:
𝜂𝜎 (𝑇) =

𝜎𝑑𝑙𝑛𝑍(𝜎,𝑠,𝑁)
𝑑𝜎

(1.66)

An alternative to matrix methods, when N is large, or N is greater than 1/σ0.5 Z and Θ simplifies
to equation 1.67 and 1.68, respectively.
1

𝑠+1+((1−𝑠)2 +4𝜎𝑠)2 ))

𝑍=

2

(1.67)

1

Θ = 2 − (1 − 𝑠)/(2 ∗ ((1 − 𝑠)2 + 4𝜎𝑠)) (1.68)
Helix and beta-sheet formation is primarily driven by van der Waals and hydrophobic
interaction, not hydrogen bond formation79. Enthalpy of helix formation is generally reported to
be 1.1 kcal/mol and assumed to be the average enthalpy of residue unfolding in a protein39, 40, 42.
This will not be the case of PLL peptides, where the h parameter will be fitted to data.
1.26.4 Circular Dichroism
With the advent of extensive protein structural libraries starting in the 1980’s (due to a
combination of various recombinant DNA technologies, X-ray crystallography, and NMR
techniques), greater insight into the role of structure played in protein function became much
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more apparent . The two analytical techniques mentioned, however, can be time and resource
consuming. Moreover, they are sometimes untenable in the case of a protein not being
crystallizable (X-ray crystallography), or if it is too large (NMR). CD, on the other hand, is
extremely robust, relatively less resource intensive, and much more amenable to rapid analysis8183

. For these reasons, CD has become a primary method for characterization of protein and

peptide structures. Applications include evaluating SS features and content80, 83, 84, higher order
features80, amino acid residue identification80, protein-protein interaction82, cofactor and ligand
binding80, 82, 85, kinetics of folding/unfolding and other kinetic processes82, 85, and most
importantly for this work, measuring the thermodynamics of SS unfolding80, 85-87.
A CD instrument is composed of five components: light source, monochromator (for wavelength
selection), polarizer, sample compartment, and detector (See Figure 1.9).

Figure 1.9. A schematic of a circular dichroism spectrometer.10

Useful CD analysis is a function of the cotton effect, where an optically active substance
absorbs light and polarized light differentially. Figure 1.10a illustrates this phenomenon in two
cases: case (I) the equal absorption of left handed (counter-clockwise) and right handed
(clockwise) light when passed through an optically inactive, symmetric sample. Case (II), left
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and right handed light are absorbed differentially due to passing through an optically active
substance. Differential absorption can be caused by multiple factors. Carbon atoms form four
bonds, potentially yielding an optically active center. Some bonds such as C-S-S-C create
dihedral angles that will produce cotton-like effects80, or an absorbing agent will be connected to
chiral center eliciting unequal absorption of polarized light. Finally, any condition in which a
chromophore is part of an asymmetric environment with different polarized light passing through
it, differential absorption will occur. In the cases of proteins and peptides, this unequal
absorption (depending on wavelength) is due to SS features (240 nm and below)80, 85,
tertiary/quaternary aggregation, and binding effects (260 nm and above)80, 82.
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Figure 1.10. Differential absorption of polarized light from CD. 11In Figure A case (I) polarized
light passes through a optically inactive sample with no difference in absorption occurring,
resulting in plane polarized light radiation as evidenced by resultant vector shown above. Case
(II), polarized light passes through an optically active light source resulting in unequal absorption
of L and R light, generating polarized radiation illustrated by the elliptical dashed line. (B) a
comparison between ordinary absorption of a chromophore and CD absorption of same
chromophore at identical wavelength. Band 1 for CD shows positive absorptions, band 2
negative and no absorption for optically inactive band 3.
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Secondary structural analysis of peptides and proteins measured in the far UV spectrum
and generally proceed through the election transitions n→π*, and π→π*81, 84, 85, 87 with the former
transition, forbidden electronically, but allowed magnetically87 and primarily responsible for the
large negative absorption band at 222 nm in alpha helices87. In addition to the strong, negative
222 nm peak, helices show a strong negative 208 nm (π→π*) and positive peak at ~198 nm,
giving the characteristic negative double peak chromatogram. Beta sheets show a strong
negative 216-218 peak. Random coils show positive and negative peaks at approximately 216
and 203 nm, respectively sheets84. Figure 1.11 provides a classical CD chromatogram of helix,
sheet, and coil SS features. Another useful feature of CD is using the combination of CD
libraries and algorithms allow breakdown SS content of complex proteins and peptides83 further
expanding its application.

Figure 1.11. A CD spectrum of helix, coil, and beta-sheet secondary structure features.12
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Like other absorption methods, CD absorption follows Beer’s law (under appropriate
concentrations ranges) concentration dependent absorption as detailed in equation 1.69:
[𝐴] = 𝜀 ∗ 𝑙 ∗ 𝐶 (1.69)
Where A is the measured absorption, ε, the extinction coefficient, l, the optical path length, and C
is the molar concentration. In the case of molar ellipticity, the Beer’s like behavior is adapted to
difference in polarized light absorption described in equation 1.70:
∆𝐴 = 𝐴𝐿 − 𝐴𝑅 = 𝜀𝐿 ∗ 𝑙 ∗ 𝐶 − 𝜀𝑅 ∗ 𝑙 ∗ 𝐶 = ∆𝜀 ∗ 𝑙 ∗ 𝐶 (1.70)
Where L and R refer to the left and right handed light. The difference in absorption results in
light that is elliptically polarized forming an angle θ, measured in millidegrees. Ellipticity and
absorption are related by the equations:
𝜃

∆𝐴 = 32980 (1.71)
𝜃=

2.303(𝐴𝐿 −𝐴𝑅 )
4𝑙

(1.72)

While most CD spectrum are recorded I in millidegrees (mdeg) most data is reported in the
concentration normalized mean residue ellipticity (MRE) which possesses the units deg.cm2/mol.
Conversion of mdeg to MRE proceeds via equation 1.73:
𝑀𝑅𝐸 =

𝑚𝑑𝑒𝑔∗100∗𝑀
𝐶∗𝑙∗𝑛

(1.73)

Where M is molecular mass, C is concentration in mg/ml l is path length in cm, and n is the
number of residues in the protein/peptide samples.
CD methods are very amenable to protein/peptide thermodynamic studies due to its
sensitivity to secondary structure changes that allows for changes in fraction folded/unfolded due
to chemical/thermal denaturation to be measured. In the case of recording changes in fraction
helicity there are numerous methods. For proteins, the most common method is to monitor
changes in ellipticity at 222 nm and assume max helicity of a given protein at 222 nm is -36,000
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MRE (deg.cm /dmol), while measured MRE for a coil is taken as -3,000 deg.cm /dmol .
Fraction helicity is then calculated according to equation 1.74:
[𝜃]−3,000

𝑓𝐻 = −36,000−3,000 (1.74)
Where θ is the measured MRE value. Other estimations include monitoring changes at 208 nm.
In that instance equation 45 holds, though max helicity and coil MRE values are changed to 33,000 and -4,000 deg.cm2/dmol, respectively. For peptides monitored at 222 nm, equation 45 is
often used as well, however, more accurate measurements can be made using equation 1.75:
𝑓𝐻 = (−36,000(1 −

2.57
𝑛

) (1.75)

Where n is the number of peptide residues.
As illustrated in equation 1.68, fraction helicity can be used to determine the equilibrium
constant K from equation 1.68, free energy can be determined at any temperature. However,
from relationship of equation 1.64 and 1.66 (relating enthalpic and entropic free energy to the
equilibrium constant K), a new useful relationship between the two can be deduced88
∆𝐺𝑜

∆𝐻𝑜 ∆𝑆𝑜
𝑅

𝐾 = 𝑒 − 𝑅𝑇 = 𝑒 − 𝑅𝑇 +

(1.76)

Provided the molar heat capacity is constant, equation can be re written as:
𝐾=𝑒

−

∆𝐶𝑝 𝑇𝑚
∆𝐻𝑚
1
1
𝑇
∗( − )+
∗( −1+ln ( )
𝑅
𝑇𝑚 𝑇
𝑅
𝑇
𝑇𝑚

(1.77)

For CD there is often insufficient information to properly fit molar heat capacity and it is
generally set to zero, further reducing equation 1.77 to the following:
𝐾=𝑒

−

∆𝐻𝑚
1
1
∗( − )
𝑅
𝑇𝑚 𝑇

(1.78)

Here ΔHm refers to the van’t Hoff enthalpy and Tm refers to the transition at the temperature, the
latter is defined as the observed midpoint thermal transition. Here curve fitting routines utilizing
Levenberg-Marquardt algorithm are used to fit the enthalpy and transition temperature.
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Alternatively, equation 1.78 can be expressed in the non-exponential form as a function of free
energy when convenient and fitted in the same function:
𝑇

∆𝐺 = ∆𝐻(1 − 𝑇 ) (1.79)
𝑚

At the Tm point free energy is zero and the equilibrium constant is 1; from equation 1.64 it can be
observed that entropy is determined from enthalpy divided by the transition temperature
∆𝑆 =

∆𝐻𝑚
𝑇𝑚

(1.80)

Thus, all transition temperatures of interest can be determined from CD techniques.
While molar heat capacity, ΔCp usually cannot be measured from single scans, it is often
determined though chemical denaturation at multiple concentrations according to equation 1.81:
𝑑𝐻

∆𝐶𝑝 = 𝑑𝑇 (1.81)
𝑚

CD requires additional sample preparation considerations. For instance, many buffers are not
compatible with CD as they absorb UV at the tested wavelength. Therefore, careful
consideration must be given when choosing buffering agents. In cases where buffers with
unfavorable characteristics are needed, complications can be mitigated through minimizing the
buffer component concentrations, and/or choosing another suitable scanning range with less UV
absorbance for said compounds.
1.26.5 Differential Scanning Calorimetry (DSC)
DSC provides valuable insight into the thermodynamic properties of peptide/protein
folding and stability of both liquid and solid formulations such as free energy, enthalpy, entropy,
molar heat capacity and the transition temperature. For solid formulations, glass transition
temperature can be determined as well.
DSC functions by measuring heat absorption from a protein/peptide as it undergoes
thermal unfolding. This is accomplished using a reference cell with identical solvent conditions
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to the sample cell minus the protein/peptide (see Figure 1.12). As heat is applied to both cells,
unfolding occurs in the sample cell resulting in heat absorption by the protein and a differential
temperature between reference and sample. Heaters on the sample cell then raise supply the
additional electric power to the cell, eliminating the temperature differential. This generally
occurs as a single peak for simple proteins. After corrections for the instrumental and transition
baselines as well as concentration normalization to the resulting thermogram, the calculated
enthalpy ΔHcal, ΔCP, and Tm can be directly determined (see equations 1.55-1.56). Additionally,
van’t Hoff enthalpy (ΔHHV) can be determined and compared ΔHcal. Under van’t Hoff, a twostate unfolding model is assumed when ΔHcal/ ΔHHV=1. Changes in free energy, enthalpy,
entropy, molar heat capacity, and transition temperature were determined from equation 5.9 to
assess changes in overall stability.

Figure 1.12. A schematic of a DSC set-up.13

1.26.6 Nuclear Magnetic Resonance (NMR)
One of the most important and structurally elucidating analytical techniques, NMR
operates on the absorption of radio waves by the sample ranging from 4-900 MHz89. NMR
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differs from other traditional electromagnetic absorption techniques operating in the ultraviolet,
visible, and the infrared portion of the spectrum. For such systems absorption involves
interaction with the outer electrons of atoms as opposed to nuclei as is the case for NMR.
Additionally, to make absorption possible, samples must be placed in an intense magnetic field
to develop sufficient energy to allow absorption to occur. Figure 1.13 provides a brief schematic
of an NMR system. There is a radio source, sample placed between two magnets, a detector and
recorder.

Figure 1.13. A schematic representation of NMR instrument components.14

All charged particles in motion have an associated magnetic field, creating a magnetic
dipole and a corresponding magnetic moment µ. When dealing with nuclei, the molecular
moment is connected to nuclei’s angular momentum quantum number, I, referred to as nuclear
spin. Magnetic moment is proportional to the gyromagnetic ration Υ as shown in equation 1.82
𝜇 = 𝛾 ∗ 𝐼 (1.82)
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Classically, NMR is often described as a spinning top precising around a uniform magnetic field
(illustrated in Figure 1.14). The movement µ traces a circle around the magnetic field as
described by the Larmor precession frequency in equation 1.83:
𝑣=

𝛾𝐵𝑜
2𝜋

(1.83)

Additionally, if a weaker magnetic field is placed perpendicular to Bo, it will cause the magnetic
moment, µ to move away from Bo and the angle θ to increase. The change in θ corresponds to a
change in resonance energy, v, which is the same as the field B1 and must equal the Larmor
precession frequency (equation 1.83)90, 91

Figure 1.14. Angular momentum of the proton in NMR. The angular momentum15µ is
represented by the arrow through the spinning nuclei, Bo and B1 represent the strong external
magnetic field and the weaker, orthogonal magnetic field, respectively, while θ represents the
angle between Bo and µ.

Typically, atomic nuclei are viewed as spheres, rotating about an axis, and possess intrinsic
angular momentum, P. Angular momentum, like most other atomic properties, are quantized as
detailed in equation 1.84:
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𝑃 = ℏ√𝐼(𝐼 + 1) (1.84)
Where ħ=h/2π (h is Planck’s Constant). The maximum number of spin states, or P values is I the
nucleus will then have 2I+1 discrete states89, 91. In the absence of an external field all states will
of course be degenerate. In the case of 1H, the only nucleus considered here, has an I value of ±
½.
As previously discussed, µ is proportional to the magnetogyric ratio and angular
momentum p (equation 1.82). The relationship between observable magnetic moment and
nuclear spin leads to observable magnetic quantum states m = I, I-1, I-2,…, -I; thus the 1H proton
will have a magnetic quantum state m=±1/2.
As stated earlier, in the absence of a magnetic field, all energy states are equivalent;
however, once placed in a magnetic field the two m states possible of 1H will split (see Figure
1.15), the magnitude of which is directly proportional to the strength of Bo as described by
equation 1.85:
∆𝐸 = 𝛾ℏ𝐵𝑜 (1.85)
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Figure 1.15. The nuclear spin energy levels of a spin-1/2 nucleus in a magnetic field.16

When placed in the magnetic field, the m=±1/2 values are no longer degenerate and will be
populated differentially with the lower energy state, m=+1/2 being more populated. By how
many protons will occupy the lower relative to the higher is described using a modified
Boltzmann equation (equation 1.86):
𝑁𝑗
𝑁0

∆𝐸

= exp (− 𝑘𝑇 ) (1.86)

Where Nj and N0 are the population of higher and lower energy states, respectively, ΔE is the
difference in energy of the two states, k is the Boltzmann constant, and T is the temperature.
Generally, difference are very small, on the order of 10-6, or parts per million, ppm89.
Fortunately, nuclei are not only subject to artificial, external magnetic fields, but are very
sensitive to nearby nuclei and their chemical environment. Given that a nucleus is surrounded by
electron(s), when it is placed in a magnetic field, they too will have induced magnetic moments,
causing them to circulate, generating a secondary, weaker magnetic field in opposition to the
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applied field (see Figure 1.16). This will cause the nucleus to be shielded in part from the
external magnetic field and is described by equation 1.87:
𝐵𝑙𝑜𝑐𝑎𝑙 = 𝐵𝑜 (1 − 𝜎) (1.87)

Figure 1.16. Magnetic field effect on electron motion and resultant induction of secondary,
opposing magnetic field.17

Equation 1.87 has important implications in identifying nuclei in a given molecule.
Given 1H in a molecule will experience a different chemical shift dependent on its neighboring
atoms, a particular 1H can be identified based on its chemical shift from a reference molecule
such as tetramethylsilane (TMS).
When observing a proton NMR spectrum, the peak of a particular nucleus will often
show a triplet or quartet signal. This often occurs because neighboring nuclei can contribute to
the local magnetic field of the nucleus. Such behavior is referred to as the spin coupling
constant, J, a scalar value. They are independent of field strength and much smaller in value
than spin values. When two different nuclei delineated as A and X, respectively, both having
spin ±1/2 and very different chemical shifts. When spins are positive or negative, they are
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referred to as α and ß, respectively. For species X, if it is α; then the spin of A’s Larmor
frequency will be shifted by -1/2 J from its combined external and shielding magnetic effects.
Likewise, if X is ß it would have a +1/2 J shift, creating doublet splitting for A, centered around
the chemical shift features of A. X would also be a doublet, only it would be centered around the
X chemical shift (see Figure 1.17a). The same process can be repeated for more similar nuclei
and is also shown in Figure 1.17a. Combinations of nuclei can be explained in number and
intensity using Pascal’s triangle (Figure 1.17b).
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Figure 1.17. In part a. splitting patterns from two dissimilar (AX) and similar (AB) nuclei are
shown. In b. splitting pattern and relative intensity based on the number of neighboring atoms are
given.18

1.26.7 Use for NMR and Peptide Secondary Structure Elucidation
Hα NMR chemical shifts in peptide backbones have long been known to be strongly
affected by their torsional angles92-95 and as such have been explored as means to elucidate SS
content, ring effects, and hydrogen bonding in peptides and proteins93, 96-98. Chemical shift
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estimations of peptide based and similar macromolecules are assumed to occur from independent
and additive factors92-94, 99 as described by equation 1.88:
∆𝛿 = 𝛿𝑡𝑜𝑡𝑎𝑙 − 𝛿𝑟𝑐 = 𝛿𝑡𝑜𝑟 + 𝛿𝑟𝑖𝑛𝑔 + 𝛿𝐻𝐵 + 𝛿𝑒 + 𝛿𝑠𝑖𝑑𝑒 + 𝛿𝑚𝑖𝑠𝑐 (1.88)
Here, rc, tor, ring, HB, e, side, misc refer to random coil or intrinsic, torsional, ring, hydrogen
bond, electric field, side chain, and miscellaneous contributions, respectively. For Hα shifts,
random coil “intrinsic” and torsional angle (ϕ/ψ) considerations contribute the most to observed
chemical shifts, followed by ring currents, hydrogen bonding, and miscellaneous contributions94.
The magnitude of contribution is enumerated in Table 1. Ignoring intrinsic, random coil effects,
it can be observed that torsional factors make up over two-thirds of Hα variation94.

Table 1.1.
Factors contributing to Hα chemical shift.2 RC refers to random coil, Tor, torsion angle, SC,
side chain, HB hydrogen bonding, and ring, ring current.
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1.27 Statement of the Problem
Formulation optimization is a time consuming, complicated experimental process. To
optimize formulations, excipients are often added to stabilize protein and peptide/protein based
biologics. Thermodynamic mechanisms responsible for stabilization of secondary structure of
biologics are not clearly understood.
1.28 Hypothesis
Excipients can thermodynamically stabilize/destabilize helix SS features in peptides and
proteins. Thermodynamic mechanistic effects can be deduced from measuring changes in
fraction helicity in SS of systems having excipients by comparing them with no excipient. Also,
excipients stabilization or destabilization may be classified based on enthalpic or entropic
dominant effects as preferential excluders/binders or crowders, respectively.
1.29 Aims
The current investigation has three specific aims: 1) Develop a model that can quantitate
excipient thermodynamic stabilization of alpha helices in peptides through peptide unfolding
using CD and verified with NMR. 2) Evaluate thermodynamic stabilization/destabilization
mechanisms of PLL alpha helices. Aim 3) Extension of peptide model to model protein, BSA
and its unfolding using DSC.
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CHAPTER 2: DEVELOPMENT OF A MODEL SYSTEM FOR INVESTIGATING
SECONDARY STRUCTURE OF PEPTIDE AND PROTEIN

2.0 Introduction
The objective of this aim is to develop a model that can evaluate excipient stabilization of
alpha helix stability in peptides through peptide unfolding. Evaluation of excipient
thermodynamic protection mechanisms, especially at different concentrations, will significantly
improve the formulation process. As discussed in the thermodynamic and introductory sections,
free energy of helix unfolding is directly linked to its stability. To determine stability
enhancement/destabilization due to excipient effect, monitoring changes in fraction helicity due
to thermal or chemical stress is needed. Briefly, this can be done through equating fraction
unfolded vs native structure with the equilibrium constant K. From K, free energy and other
thermodynamic parameters of unfolding can be determined. In setting up a suitable model,
several factors need to be considered, such as the composition of the testing system, model
peptide, solvent conditions, and types of excipients to evaluate. The general model will consist
of three components: NaOH pH adjusted buffered solution (pH 11.7), a model peptide, and
selected excipients at various concentrations. The model will then be subjected to thermal
challenges and changes in fraction helicity and corresponding free energy recorded and plotted to
evaluate changes in thermodynamic properties.
Few studies have looked at the thermodynamics of unfolding of specific SS features. The
only studies that have looked at unfolding in specific SS unfolding are hydrogen deuterium
exchange (MS_HDX) studies of lyophilized proteins/peptides100. To the best of my knowledge,
no studies have directly measured change in thermodynamics of helix unfolding in
peptides/proteins in liquid solutions.
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PLL as a model peptide was chosen as it forms monomeric helix formation, chemical
environments alter its SS, and its high solubility. PLL is a homo-polymer capable of adopting
various SS depending on solvent conditions101-103. At pH less than 10.6, it adopts a random-coil
extended helix structure but will transition to an alpha helix when the pH exceeds 10.6 due to
the side-chains becoming deprotonated at high pH101. Upon heating above 55oC for an extended
period of time, then cooling, PLL will slowly and irreversibly form a beta-sheet SS103.
Below55oC heating is reversible104 and two state. The degree of helicity at high pH is both a
function of temperature and PLL size. Large PLL polymers will adopt a mostly helical structure
at room temp, while smaller polymers will exist as partial helices at room temp and even 0 οC103,
105

. Here a 20-mer PLL polymer was chosen, as this represents the maximum length helix that

would typically be found in a protein. Additionally, at this size, PLL fraction helicity will be
more sensitive to solution conditions than larger analogs while also existing in monomeric form,
simplifying results.
2.1 Excipient Selection
Excipients come in many classes and are included in formulations for a variety of
protective and functional purposes. Here, three types of excipients are evaluated, polyols,
disaccharides, and polymers represented by mannitol, trehalose, and PEG400, respectively. The
former two are purported to be excluded from the peptide backbone, enthalpically stabilizing
biologics15, 16, 106, 107, polymer PEG400 is generally described as a crowder108. Mannitol, one of
the most commonly used biologic excipients109, has served many functions ranging from tonicity
agent, bulking agent, lyoprotectant110, osmolyte, and conformational stabilizing agent as
previously mentioned. Trehalose likewise is found in a variety of formulations, a common
lyoprotectant, kosmotrope, and osmolyte9. Like mannitol, it has been found to be excluded from
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protein surfaces which effects may be concentration dependent

106, 111

. PEG400 is used in both

liquid and solid formulations and has been is used as a crowding, or tonicity agent, or plasticizer.
In liquid formulation it is often described as a crowding agent entropically stabilizing
biologics108; however, due to its hydrophobic and enthalpic regions, it may preferentially bind to
hydrophobic regions of a protein and peptide, thereby destabilizing it51, 56, 108. Urea was
evaluated as negative control due to its denaturation effects which result from preferential
binding and its chaotropic nature74, 78, 112, 113. Such destabilization will allow greater comparison
of thermodynamic interaction mechanisms as well as a means to evaluate protective excipients
against a chemical desaturating environment.
2.2 Model System for Thermodynamic Analysis
The model peptide system consists of three different systems: system #1, PLL in a
buffered aqueous solution (pH 11.7) undergoing thermal stress. System #2 contains all
components of the first in addition to tested excipients mannitol, trehalose, PEG400, and urea all
at different concentration gradients. Like the previous system, system #3 contains PLL, buffered
solution and excipients of system #2; however, mannitol, trehalose, and PEG400 are all held at
constant concentration of 0.5M, individually against varying concentrations of urea while
exposing to thermal denaturation (see Figure 2.1).
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Figure 2.1. Peptide unfolding model. Red circles represent tested excipients, including urea in
system #2. In Figure #3, yellow circles represent urea while red represent mannitol, trehalose,
PEG400. Loss in peptide SS measured with CD is observed with loss in MRE absorption at 222
nm. The loss of MRE with increasing temperatures is correlated with corresponding loss of
helicity using equation 1.79.19

The thermodynamics of each system can be determined through monitoring changes in
helicity using CD spectroscopy and NMR (used in system #3). As shown in Figure 2.1, thermal
stress will induce loss of helicity (left figure). Excipients added will result in changes in the

81
enthalpy, entropy, and overall free energy of the system and will be determined through the
following relationship:
∆∆𝑋 = ∆𝑋2 − ∆𝑋1 (2.1)
Where X represents G, H, or S, allowing the quantification of helix stabilization to be measured.
It should be noted that TΔΔS T = 298 K. Furthermore, from system #3, ΔCp can be evaluated
and used to monitor changes in ΔCp with excipient type.
2.3 Materials and Methods
Materials were purchased from Alamanda Polymers with a purity greater than 95%. All
excipients, urea, NaOH, and NaCl were purchased from Sigma Aldrich, St. Lois, MO, at 95% or
greater purity and were used without further purification. PLL was weighed then diluted to stock
concentration in NaOH solution with 10mM NaCl, to a concentration of 15 mM and adjusted to
a final pH of 11.7. Excipient stock solutions were prepared at max desired concentrations then
serial diluted to the desired concentrations of 0, 0.1, 0.25, 0.35, 0.5, 0.75, 1.0 M at pH 11.7.
Stock PLL was added to each excipient dilution at a 100x dilution ratio for a final PLL
concentration of 150 µM. All systems were then subjected to thermal stress as described in the
CD analysis sections. Additionally, the effect of pH on PLL SS conformation was assessed. For
conformational studies, PLL was prepared at 150 µM at pH 7.4 (10mM NaCl in PBS buffer) and
at pH 11.7 in 00.5mM NaOH and 10mM NaCl. Blanks with buffers and excipients were run to
later be used to subtract background noise from samples.
2.4 CD Analysis
CD-UV analysis was done on a Jaso-810 CD spectrometer with an attached Peltier and
0.1 cm quartz cuvette. CD spectra were recorded in triplicate with a scan rate of 100nm/min,
1mm slit width with excipient/buffer solutions as blanks. HT values did not exceed 600 V for
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recorded data. Full scan spectra were acquired from 200-260 nm at 20 C. Thermal denaturation
was carried by increasing the temperature from 20°C to 50°C at a rate of 0.5°C/min.
Data analysis: All data was collected in mdeg then converted to MRE using equation
5.29; fraction helicity was then determined from equation 5.30 while equilibrium constant K and
free energy ΔG were determined from equation 5.30 and 5.23, respectively, for all data points
using Excel 2016. Data was then plotted in Prism 6 using equation 5.36 and fitted with the
Levenberg-Marquardt algorithm.
2.5 Results and Discussion
2.5 1 CD Analysis of Secondary Structure
Full scan CD spectra for neutral and basic pH solutions is shown in Figure 2.2. It can be
seen at neutral pH (the orange line) the sample is indeed a coil, with positive peak in 210 to 225
nm range and negative peak at 198 nm. PLL at the high pH conditions (grey line) bears the
trademark negative peaks at 222 and 208 nm, with trending large peak in the mid 190s range
indicating a peptide helical in nature. At 194 nm the voltage exceeded 600 V and all data at
lower wavelengths was not used. From Figure 2.2 it can be confirmed PLL does possess coil
and helix SS features at the literature purported pH values.
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Figure 2.2. PLL full scan CD spectrum in neutral and basic solutions. The orange line represents
PLL at pH 7.4 in PBS solution and the grey line, PLL at pH 11.7. The helix trademark double
negative peaks are observed (black pH 11.7), while coil features are observed at pH 7 (orange)
solution.20

2.5.2 Effect of Temperature on PLL MRE and fH
Stabilizing additives can not only alter helical content due to preferential hydration or
crowding effect but reduce unfolding due to thermal stress. CD thermal denaturation studies of
PLL in increasing concentrations of mannitol were done (Figure 2.3) and monitored at 222 nm
(as detailed in the methods section). Additionally, the effect of chemical and thermal
denaturation via urea (0.75M shown in Figure 2.3) was done. From the figure it can be seen that
mannitol concentration decreased MRE at 222 across all temperature ranges relative to PLL with
no mannitol while 0.75M urea increased relative MRE of PLL (Figure 2.3a). MRE was
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correlated with fraction helicity (Figure 2.3b) using equation 5.31, showing mannitol increased
fraction helicity while urea decreased it.

Figure 2.3. Effect of mannitol on PLL MRE (a) and fH (b). 21

It should be noted the slight sigmoidal shape of PLL while undergoing thermal
denaturation and the reasons why. As mentioned earlier, PLL does display some unique
unfolding properties. At temperatures exceeding 55oC it begins to fold into beta sheets
irreversibly104. Below this temperature it interchanges between helix to coil structure,
reversibly104. Complex interactions between helix to coil and coil to sheet may complicate the
unfolding process due to poor cooperativity of peptide unfolding/folding41, 114, 115, which can
affect curve shape. Such behavior for example has been observed in certain slow unfolding
helical peptides114. However, change in MRE and the corresponding fraction helicity are
consistent with the expectation of the effects of excipient concentration and type, and gave
consistent results through multiple experiments and analysis.
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2.5.3 Effect of Excipients on PLL Unfolding Thermodynamics
Through thermal unfolding of PLL in the presence of various excipients at increasing
concentration, changes in ΔΔH, TΔΔS, and ΔΔG were determined. Observations were recorded
in Table 2.1 and Figure 2.4.
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Table 2.1.
ΔΔX of PLL unfolding in the presence of mannitol.3

Figure 2.4. ΔΔX of mannitol on PLL a.) ΔΔH effects of mannitol on PLL unfolding. b.) Plot of
TΔΔS PLL helix unfolding. c.) Plot of ΔΔG PLL helix unfolding. 22
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An increase in ΔΔH is observed at all concentrations of mannitol; however, offsetting
TΔΔS destabilization is observed reducing enthalpic stabilization. Near max enthalpic/entropic
changes were observed at low concentrations creating an apparant plateau. However, net ΔΔG
stabilization occured in a concentration dependent manner due to slight variations and increases
in ΔΔH relative to smaller TΔΔS changes (Table 2.1 and Figure 2.4c).
Similar trends are observed with trehalose as shown in Table 2.2 and Figure 2.5 with
increased enthalpic stabilization occurring at all trehalose concentrations, with a significant
increase at the highest 0.75 M trehalose concentrations. Similar to mannitol, entropic
destabilization is observed at all concentrations. Net stabilization of free energy is observed
from 0.25-0.75 M trehalose. Surprisingly, trehalose thermodynamic parameter value changes
were less in magnitude than mannitol. Trehalose was expected to be a stronger kosmotrope due
to its larger size and greater number of oxygen atoms; however, mannitol effects were stronger.
This is attributed to mannitol being a potentially stronger osmolyte than trehalose.

Table 2.2.
ΔΔX of PLL unfolding in the presence of trehalose. 4
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Figure 2.5. ΔΔX effects of trehalose on PLL23a.) ΔΔH effects of mannitol on PLL unfolding.
b.) Plot of TΔΔS PLL helix unfolding. c.) Plot of ΔΔG PLL helix unfolding.

PEG400 data, shown in Table 2.3 and Figure 2.6, differs from the mannitol and trehalose
as there are minimal changes in the low to mid range concentration. Enthalpy stabilization is
largely offset by entropy destabilization. At higher concentrations PEG increases ΔΔH
significantly.
PEG400 has complicated, concentration-dependent effects on enthalpy, entropy, and free
energy changes. The -CH2 portion of PEG400 has the potential to preferentially interact with the
peptide backbone and other hydrophobic portions of the ligand. Such interactions may be
significant at the low to intermediate concentrations. Additionally, entropic stabilization was
important at the low to intermediate concentrations. At high concentrations enthalpic
concentrations dominate. Further discussion in later sections will explore these effects.
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Table 2.3.
ΔΔX off PLL unfolding in the presence of PEG400.5

Figure 2.6. ΔΔX effect of PEG400 on PLL unfolding. 24a.) ΔΔH effects of PEG400 on PLL
unfolding. b.) Plot of TΔΔS PLL helix unfolding. c.) Plot of ΔΔG PLL helix unfolding.

Urea decreases ΔΔH at all concentrations, plateauing at 0.35M with similar compensating
TΔΔS stabilization increases with urea concentration, less so than enthalpic destabilization
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(Table 2.4 and Figure 2.7). Overall, free energy destabilization was observed, plateauing at
0.335M urea concentration. Urea enthalpic destabilization was expected given its chaotropic
nature. The plateau effects beginning at intermediate concentrations could be explained by the
relatively small size of the PLL polymer being studied. Large globular proteins can show linear
concentration dependent decreases in ΔΔG over large urea concentrations74. PLL, however, does
not have tertiary and multiple SS features to unfold, and its smaller surface area may get
saturated at lower concentrations. Smaller more incremental increases in urea concentration may
have allowed for a linear effect to be observed.

Table 2.4.
ΔΔX of PLL unfolding in the presence of urea.6
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Figure 2.7. ΔΔX of PLL unfolding in the presence of urea. 25 a.) ΔΔH effects of mannitol on
PLL unfolding. b.) Plot of TΔΔS PLL helix unfolding. c.) Plot of ΔΔG PLL helix unfolding.

2.5.4 Effect of Chemical and Thermal Denaturation of PLL Unfolding Thermodynamics
PLL in the presence of 0.5M mannitol, trehalose, or PEG were chemically denatured
using a urea gradient as well as thermally denatured at each urea concentration. Results from the
preceding experiments are shown in Figure 2.8 for changes in enthalpy, entropy, and molar free
energy. ΔΔH decreases linearly with urea concentration but remains positive for up to 0.5M
urea. TΔΔS (Figure 2.8b and Table 2.5) likewise decreases in a concentration dependent
manner, positive and destabilizing at lower concentrations; however, at higher concentrations it
becomes negative and partially stabilizes PLL entropically, with overall destabilization observed.
ΔCp increases in the presence of mannitol; however, such increase is small and falls within the
error range of PLL without mannitol.
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Trehalose shows a linear decrease in enthalpy with increasing urea concentrations, with
the only positive ΔΔH observed without the presence of urea. Entropic results mirror those of
enthalpy, and overall trends follow those of mannitol, but less in trehalose. As with mannitol,
there is no significant difference between trehalose stabilized PLL and no trehalose.
PEG400 shows similar behavior to system #2, where initial low/mid concentrations had minimal
stabilizing effects or were slightly destabilizing. Here, enthalpy remains fairly constant until
reaching 1M urea. Similar results are observed entropically where changes remain fairly constant
while decreasing at the highest urea concentration. PEG400 effect on ΔCp cannot readily be
discerned due to significant standard deviation.

Table 2.5.
Effect of urea on ΔΔX in the presence of 0.5M excipient.
PLL Excipient
Urea Conc. M
ΔΔH
Conditions
No Excipient
0
0.00±7.07x10-2
Mannitol
0
0.823±5.54x10-2
(0.5M)
0.25
0.397±4.99x10-2
0.5
0.159±3.08x10-2
1
-0.864±6.32x10-2
Trehalose
0
0.231±7.61x10-2
(0.5M)
0.25
-0.793±4.81x10-2
0.5
-1.43±0.171
1
-1.64±0.191
PEG400 (0.5M)
0
-1.06±6.88x10-2
0.25
-1.06±6.88x10-2
0.5
-0.930±5.58x10-2
1.0
-3.17±8.13x10-2

TΔΔS (T=298K)

ΔCP

0.00±3.53x10-2
0.124±2.49x10-2
-0.178±2.49x10-2
-0.249±2.40x10-2
-1.08±3.16x10-2
-0.255±3.81x10-2
1.04±2.40x10-2
-1.43±8.55x10-2
3.93±9.53x10-2
-1.29±3.44x10-2
-1.29±3.44x10-2
-0.941±2.79x10-2
-3.21±4.04x10-2

1.98x10-2±3.99x10-2
2.35x10-2±1.90x10-3

1.59x10-2±4.04x10-3

-1.98x10-2
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Figure 2.8. Urea and mannitol effect on PLL in the presence of 0.5M mannitol, trehalose,
PEG400 with increasing urea concentrations26a. ΔΔH against urea concentration, b. TΔΔS
against urea concentration shown, and c. Table of ΔΔH, TΔΔS and ΔCp shown.

Mannitol and trehalose both stabilized PLL alpha helices against thermal unfolding,
increasing the enthalpic penalty of doing so with increasing concentration. While the ΔΔH
effects were similar between the two additives, mannitol showed greater enthalpic stabilization
than trehalose. Interestingly, enthalpic stabilization was offset partially by loss of entropy,
somewhat negating the enthalpic stabilization; however, overall free energy stabilization was
observed. PEG400 showed no significant effect (p-value 0.680) on PLL unfolding either
entropically or enthalpically, except at the higher concentrations, ΔΔH increased. Urea
significantly decreases ΔΔH but plateaued at the mid concentrations. Unlike mannitol and
trehalose, enthalpic destabilization was offset entropically by urea; however, it was less in
magnitude than enthalpic destabilization.
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When holding mannitol, trehalose, and PEG400 concentrations constant at 0.5 M, while
increasing urea concentrations, several effects on ΔΔH and TΔΔS were observed. Mannitol
maintains its enthalpic stabilization up to 0.5M urea concentrations. Interestingly, urea seemed
to stabilize PLL entropically despite the presence of mannitol, with stabilization increasing with
urea concentration. Urea had this effect on all tested excipients. Like system #2, trehalose
behaved in a similar manner to that of mannitol, but less in magnitude. PEG 400 was
destabilized enthalpically at all concentrations, however such destabilization remained relatively
flat, until 1M urea.
The effect of 0.5M excipients on PLL ΔCp (estimated through chemical denaturation)
was minimal and statistically insignificant; however, it was observed that mannitol ΔCp may
trend higher in heat capacity effects. Stabilizing excipients would be expected to increase ΔCp as
the difference in heat capacity of the native vs unfolded state would be higher in energy. Though
excipients showed a trend in molar heat capacity increase, the effects cannot be stated due to the
relatively small values and comparatively large error bars.
Overall, excipients showed concentration dependent effects on helix stability/instability
depending on the type of excipient. Mannitol and trehalose stabilization increased with higher
concentrations and PEG400 decreased with higher concentrations, though it was a stabilizing
agent at low to mid concentration.
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CHAPTER 3: CONFIRMATION OF ALPHA HELIX STABILIZATION USING NUCLEAR
MAGNETIC RESONANCE

3.1 Introduction
CD is an excellent analytical technique to assess changes in secondary structure in
proteins and peptides; however, NMR provides an orthogonal SS validation technique. Through
use of chemical shifts of the alpha proton (αH), identification of SS features can be achived116 as
discussed in detail in the introduction sections.
Due to the significance of torsional effects, chemical shifts of Hα continue to be an area
of interest to chemists seeking to quantitate SS of complex protein and peptide structures. Early
studies were hindered due to the complex, convoluted spectrum in this region with little hope of
resolution. Work shifted to small peptides, especially homopolymers as their spectrums
presented less of an obstacle towards interpretation. However, such examples proved an
insufficient model to whole proteins and peptides as they were generally analyzed in nonaqueous environments, possessed significant poly dispersion index (PDI) characteristics, and
formed limited SS features under nonstandard conditions. As a result, such studies ceased.
Instead, NMR analysis of protein structural features blossomed with the advent of more powerful
NMRs, cross correlation techniques such as NOESY, and isotopically labeled proteins. Such
techniques along with X-ray crystallography allowed for the compilation of large libraries of
detailed protein and peptide structures. Protein databank libraries along with data mining and
statistical analysis approaches allowed for the cataloging of Hα shifts of amino acids contributing
to SS elements in proteins, establishing a chemical shift index (CSI) of said residues relative to
their intrinsic random coil state. CSIs adjacent techniques have renewed interest in the analysis
of Δδα for protein/peptide characterization in a variety of disciplines. However, one area that has
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received little exploration since Hα changes with homopolymers has ceased is its change with
respect to denaturative conditions. Use of Hα shifts under such conditions would perhaps aid in
evaluating local protein unfolding. To that end, studies of a homopolymers representative of
proteins and peptides were carried out using NMR and CD for conformation.
Having an appropriate homopolymer peptide offers a significant advantage in this regard
as peaks in the desired region are relatively simple to assign and provide a proof of concept, and
clean, quantitative means to monitor unfolding of peptide and protein SS. Here a 20mer poly-llysine (PLL) was used as a model peptide as it can form helices, beta sheets and coil structures in
aqueous environments within appropriate pH conditions. Additionally, it forms monomeric
helices even at the relatively high concentrations required for adequate NMR signal strength and
can be obtained without a large poly dispersion index (PDI), a problem for earlier studies94.
Additionally, PLLs of this size form partial helices with increasing/decreasing helicity possible
upon addition of cosolutes or change in temperature. CD is a common method for
peptide/protein structure ellucidation80, 83, 85, 117, and was used to determine the fraction helicity
(fH) of PLL. Changes in Δδα under varying temperature and cosolute conditions were recorded
to evaluate the degree of correlation with fH as determined via CD. Studies assessing PLL
fraction helicity (fH) were evaluated using chemical shift methods and compared against circular
dichroism (CD). Moreover, effects of thermal and chemical denaturation on helix PLL
unfolding were also performed and evaluated against fH as determined via CD. Such a model
can provide useful insight in Hα changes with helicity in a small, simplified model and may be
applied to larger proteins to better understand local protein unfolding through NMR.
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3.2 Method
Samples were prepared the same as that of CD; however, concentrations of PLL ranged
between 10-20 mg/ml in water with 30 ul D2O (for signal locking). Samples were run on a
JOLE 800MHz NMR using HNMR with Dante suppression of the water peak. Samples were
analyzed at 5K intervals ranging from 300 K to 320 K. Sample analysis and peak assessment
were evaluated using JOEL software.
Changes in chemical shift from random coil were first assessed through aligning all β, γ,
δ, and ε proton peaks to the random coil PLL (pH 7) at 300 K, as these peaks did not
significantly shift with temperature increases. From here, changes in αH were measured through
comparing Hα peaks at pH 7 (coil) compared to helix solutions (pH 11.7) at varying
temperatures. Max helicity was measured from a PLL solution of 50:50 MeOH and water at
room temperature 118. The fraction helicity was determined by dividing the difference between
chemical shift coil and observed chemical shift and max helicity from the PLL methanol: water
sample at each respective temperature. Data was plotted and evaluated in the Graph Pad Prism
software, version 6 and Excel.
3.3 Results and Discussion
3.3.1 Identification of PLL Protons and Temperature Effects
Proton 1HNMR of PLL is shown in Figure 3.1; where all protons are identified. From the
most shielded to least shielded (ppm), each proton is listed as follows: γ at 1.1, δ 1.3, ß 1.6, ε at
2.9, α and α’ at 4.15 and 4.05 ppm, respectively. The amide bonds are barely visible at ~8.0
ppm. Regarding the α peaks at 4.15 and 4.05, they refer to internal and external α protons,
respectively119. The peaks for ß, δ and γ are poorly resolved as PLL is a polymer, and small
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differences in the same proton type (due to its location in the helix/coil structure) cause only
small chemical shifts and overlap with each other.

Figure 3.1. α1HNMR of PLL.27

Effect of temperature on αH chemical shift was observed and recorded in Figure 10.2a.
As can be seen from the Figure, chemical shifts for the ß, γ, δ, and ε do not change with
temperature; however, αH chemical shifts do change with temperature (Figure 3.2b). For
peptides, helices and coil chemical shifts are demarcated at 4.21 and 4.14, respectively92, 96, 116,
120

. Thermal denaturation of PLL from 300-320K at 5K increments caused αH of the helical

peptide to shift downfield with temperature increases (Figure 3.2b) due to deshielding from loss
of the oxygen proximity to the alpha proton121, while the 4.14 coil alpha proton remains constant.
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Figure 3.2. Temperature effects on the chemical shift of the different PLL protons. 28

3.3.2 Fraction Helicity Through NMR and Thermodynamic Effects of Excipients
Shifting of helix alpha protons downfield is associated with loss of helicity92, 97, 121, 122.
To quantitate change in PLL helicity, comparison of αH chemical shift at max helicity vs coil
structure was performed. PLL adopts its highest fraction helicity under MeOH:H2O solvent
conditions, while it exists in a coil configuration at pH 7 in an aqueous environment. A far UV
full CD scan from 190-260 nm was carried out for PLL at pH 7, 11.7 (in buffered aqueous
environment) and with MeOH:H2O solvent conditions resulting in coil, partial helix, and helix
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SS character, respectively (Figure 3.3a). It can be seen that helicity in the organic/aqueous
environment is greater than that of the basic PLL solvent system, while neutral pH PLL solution
is clearly coil. Normalizing all recorded αH chemical shifts at different temperatures to that of
the organic/aqueous system was done to estimate fraction helicity and compared to that of CD.
The effect of 0.5M mannitol on thermal denaturation and chemical denaturation of helical
PLL was then examined. (Figures 3.3b and Table 3.1). The data show with an increase in
temperature, fraction helicity decreased as measured NMR, corroborating CD data; however, the
extent of increase is different between the methods. For PLL systems, the rate of decrease is
greater in CD with a slope of 0.363±0.237 and reasonably linear correlation of r2 0.857 being
observed. However, when in the presence of 0.5M mannitol and increasing concentration of
urea, rate of PLL helix unfolding increased faster with NMR with slopes of 2.32±0.0321,
2.36±0.278 and 3.44±0.723 for 0, 0.5, and 1M urea concentrations, respectively. Mannitol as in
the case of CD increased the helicity of PLL, and hindered unfolding. It was observed that
mannitol protected PLL helix chemical unfolding up to 0.5M urea compared to PLL only at pH
11.7. Reasons for discrepancies likely stem from the slight changes in chemical shifts of alpha
helices caused by helix unfolding (~0.1 ppm) compared to relatively large changes in molar
ellipticity (measured as MRE) which can range in magnitude by tens of thousands of
deg*cm2/dmol. Measuring small changes in chemical shift are more likely to be subject to error
and poor precision. While there was poor correlation between the two methods, trends in
increased unfolding due to thermal and chemical stress were observed for both methods. Given
CD is an established analytical method for protein and peptide unfolding, results obtained from
CD were used to calculate thermodynamic parameters due to loss of helicity. However, having
an orthogonal confirm loss of helicity was desirable.
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Figure 3.3. In a. a full far UV scan of PLL at different pH and solvent conditions is shown. In b.
changes in helicity of PLL due to temperature and urea denaturation are shown. Here, gray is
PLL at pH 11.7, no mannitol; light blue, PLL with 0.5M mannitol; green, 0.5M mannitol and
0.5M mannitol, and dark blue 0.5M mannitol and 1M urea.
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Table 3.1.
NMR-CD plot slopes.
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CHAPTER 4: AIM 2: ELUCIDATING EXCIPIENT THERMODYNAMIC STABILIZATION
MECHANISMS OF HELICAL PEPTIDES

4.1 Introduction
Biologics are relatively large, complex, and fragile molecules, subject to physical and
chemical degradation. Other factors such as solubility, viscosity, and pH need to be tailored to
meet delivery conditions and improve patient comfort and compliance. At times, such factors
may complicate the overall stability. For example, solubilization enhancement often reduces the
free energy unfolding,8, 9 increased concentration increases the risk of aggregation and increases
viscosity, making injections more difficult. However, reducing viscosity increases the risk of
aggregation. Biologics may demonstrate ideal stability at pH levels not acceptable to
intravenous administration. Additionally, many small molecule pharmaceutics are formulated
together to enhance therapeutic effects and patient compliance. No such strategies have been
successfully achieved with biologics123. Meeting such formulation demands often requires
complex excipient compositions with each component possessing stabilizing/destabilizing
features. Excipient interactions may vary with type and concentration, thus being able to classify
such excipient protection mechanisms under a variety of conditions is desirable.
The enthalpy-entropy compensation (EEC) is a phenomenon observed across a wide
variety of chemical processes107, 124-129, and is pertinent to drug design and protein
folding/unfolding. The overall change in free energy of any chemical reaction is, of course,
governed by compensating/competing components enthalpy and entropy130. Briefly, EEC occurs
when enthalpy and entropy offset one another minimizing free energy change. This is classically
observed with the transfer of alkanes and alcohols to aqueous solutions, which is enthalpically
favored, but entropically unfavored by a factor of 2-3,127 offsetting enthalpy and minimizing the
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change in free energy. Many explanations for EEC have been provided, ranging from statistical
mechanical models using many micro-states128 to supplemented hydrophobic effect models125-128,
130

i.e. solvent surrounding the protein/peptide and cosolute/excipient “feel different” relative to

solvent of the bulk solution. For example, a protein surface where water is strongly ordered,
comes into the vicinity of a relatively hydrophobic cosolute, energetic water surrounding the two
species is released, increasing the entropy of the system, favoring the process; however, this
comes at the expense of formerly strongly bound water at the surface being broken to less
energetic bulk solution interactions. Moreover, loss of entropy of a solute/effective ligand upon
binding also needs to be considered (this is especially relevant in the case of ligand design). This
overall process is shown in Figure 4.1.

Figure 4.1. Enthalpy-entropy compensation effect of an excipient on a peptide/protein.29

The opposite is true for protein/cosolutes when the two species repel (strong water
ordering around each other, no interaction) creating a greater hydration shell that is enthalpically
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driven, offset by the loss of entropy of the local water molecules. In both cases,
folding/unfolding is hindered/helped through net enthalpic means while both are offset
entropically. Thus, we see another molecular explanation of the exclusion/inclusion theory of
protein/peptide stabilization. Such discussion can naturally be extended toward neutral
crowders: lack of space for peptide/protein unfolding creates a stabilizing entropic penalty
towards unfolding yet reduces the number of potentially high energy bound water molecules,
creating net entropic stabilization overall. Given the complex nature of both biologic solute and
excipient cosolute, determining which free energy component prevails in physical stabilization
can be difficult to predict.
EEC generally follows a linear relationship towards whatever process is being monitored,
i.e. ligand binding strength/size, protein stabilization through excipient addition, etc., and
maintains this linear relationship through a wide temperature range (150-300K)127. From protein
unfolding studies reported on by Liu et al, of 3,224 proteins, a strong correlation between
enthalpy and entropy was observed with a correlation coefficient of (0.991) reported, a slope of
(0.909), observed and P<(0.001)126. Moreover, with a slope so near unity indicates any change
in enthalpy will be offset by entropy131, resulting in small free energy changes. Free energy vs
enthalpy, however, showed little to no correlation with changes in ΔH and ΔG, indicating their
independence from each other126. Given the linear nature of EEC, plotting entropy of unfolding
vs enthalpy of unfolding can provide insight into the entropic stabilization of peptides or
proteins, especially when delineating said graph into quadratic regions via diagonals through the
origin (see Figure 4.2).
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Figure 4.2. A generic graph of EEC for peptide is shown.30Regions I-IV indicate if an excipient
is stabilizing/destabilizing by primarily enthalpic or entropic means. Regions I and IV are
entropically and enthalpically destabilizing, while conversely, regions II and III are likewise
stabilizing. Arrows indicate excipient concentration gradient.

Figure 4.2 divides the EEC plot into four regions. The top half (regions I and IV) are
entropy and enthalpy destabilizing, while the converse is true of regions II and III. The arrows
indicate increasing excipient concentration. It is observed through the increasing blue circle
excipient concentration in regions I and II that an enthalpic compensation is gained but stability
is largely offset by loss of entropy. Black circles indicate concentration dependent excipient
entropic stabilization as indicated from the non-unity slope. Increased distance from the
diagonal indicates increased stabilization by entropic means. Such stabilization by excipients is
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likely the result of crowding effects. Like region II, region IV possesses non-unity EEC effects
and is enthalpically denatured.
EEC plots have several uses in studying protein/peptide behavior for many processes.
Recently, Pechl published a novel study detailing folding mechanisms and stabilization of
antibodies and development stabilization in vivo using enthalpy-entropy plots129. Sukenik and
company utilized a similar strategy to that of (Figure 4.2) to characterize salt, polyols and
polymer stabilization of protein unfoling107.
Similar to the Sukenik et al study, EE plots were employed to show the addition of
concentration effects and unfolding of helices rather than whole peptides. Such work allows for
better understanding of excipient stabilization mechanisms of helices in a concentration
dependent manner, allowing for robust and improved formulation strategies.
4.2 Methods
CD data from systems 1, 2, and 3 were used to construct enthalpy-entropy plots and
assess mannitol, trehalose, and PEG effects on EEC regarding the unfolding of PLL alpha
helices. All enthalpy and entropy data were compared to system #1 to determine ΔΔH and
TΔΔS values. For system #2 this involved measuring relative changes in enthalpy/entropy due
to increasing additive concentrations. For system #3, stabilizing excipients were added at 0.5M
concentrations and tested against chemical denaturation of urea at 0.25, 5.0 and 1M urea.
4.3 Results and Discussion
From Figure 4.3 and Table 4.1 it can be observed that mannitol at low, medium, and high
concentrations fall within region II (enthalpic stabilization). The entropy/enthalpy compensation
effect with concentration possesses a slope of 0.797± and r2 of 0.999 (Table 4.2). Trehalose also
demonstrated enthalpic stabilization at low, medium, and high concentrations (region II) that
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2

became more pronounced with concentration, possessing a slope of 0.674±0.0202 and r 0.948.
In the lower concentration ranges, PEG400 demonstrates enthalpic destabilization (region IV),
entropic destabilization (region I) in the mid concentration ranges, and entropic stabilization
(region II) at 0.75M. Moreover, PEG400 showed a linear relationship with increasing PEG
concentration with a slope of 0.764±0.0793 and r2 0.997. Urea, on the other hand, showed slight
enthalpic destabilization, largely offset by entropic stabilization effects at the low concentrations
(0.1 and 0.25M), enthalpic destabilization becomes more pronounced from 0.35M and beyond.
Entropy/enthalpy slope were very even at 0.924±0.0174 and r2 of 0.999.
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Figure 4.3. EEC plot of PLL. Part a.) an EEC plot at T=298K of PLL in the presence of varying
excipient concentrations. In part b.) a table of slope and r2 values of mannitol, trehalose, PEG400
and urea.
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Table 4.1.
EEC classification by excipient and concentration.

Table 4.2.
Entropy/enthalpy slope and r2 for system #2 with CD data.
Excipient
Slope
Mannitol
0.707±1.26x10-2
Trehalose
0.681±0.260
PEG400
0.975±0.575

r2
0.998
0.777
0.993

When assessing the stabilization mechanisms of mannitol, trehalose and PEG400 from
chemical denaturation through increasing urea concentrations, it was found that mannitol
enthalpically stabilized PLL from 0.25 to 0.5M urea; however, at the higher urea concentrations,
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enthalpic destabilization effects dominate (Figure 4.4 and Table 4.2). The relationship between
urea concentration and enthalpy-entropy effect is linear, with a slope of 0.707±0.0126 and r2
being observed. Trehalose likewise is enthalpically stabilized at low urea concentration but is
destabilized at 0.5M and above. Interestingly though, the mechanisms of destabilization
switches from entropic to enthalpic at 0.5M and 1M, respectively. Moreover, the changes in
enthalpy vs entropy are less linear in nature, possessing a slope of 0.681±0.260 and r2 of 0.777.
PEG400 at 0.5M has little effect on PLL stabilization even without the addition of urea as was
observed for system #2 (Figures 3.6 and 3.7); urea concentrations did not change this effect
much in the low to mid urea concentrations, though it did affect its urea’s location in the EEC
plots. Without PEG, urea EEC effects straddled the diagonal between regions III and IV ranging
from ~ -1 to -10 kcal/mol entropically and enthalpically, up to 0.25M urea. At 0.35M and above
~ -26 kcal/mol and ~ -25 kcal/mol was observed enthalpically and entropically, respectively, in
region IV enthalpically destabilizing PLL alpha helices. However, with the addition of 0.5M
PEG400, the magnitude in changes were mitigated with enthalpy and entropy magnitudes
ranging from ~ -0.7 to ~ -3 kcal/mol from 0.25M to 1M urea, respectively (Figure 4.4).
Moreover, despite having minimal effect on PLL helix thermal stability, PEG400 increased the
entropy/enthalpy compensation with increasing urea concentrations as evidenced by the PEGurea data points nearly straddling regions III and IV of the EEC plot, lowering the overall
destabilization effects of urea. Like the other excipients, urea EEC effects had a linear
relationship with urea concentration, and was near unity with a slope of 0.975±0.0575 and r2
0.993 being observed. Comparing Tables 2 and 3, it can be seen that EEC is near unity for urea,
while trehalose skews the strongest towards enthalpy (slope 0.574±0.0202) followed by PEG400
and mannitol, and that urea has little to no effect on these slopes; however, when comparing
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magnitude of ΔΔH/TΔΔS, urea significantly mutes the change in enthalpy and entropy. For
example, in Figure 4.4, trehalose at 0.5M enthalpy is ~ 18 kcal/mol while change in entropy is ~
13 kcal/mol. In Figure 3.5, at 0.5 trehalose and 0.25 M urea both values are less than 1 kcal/mol.

Figure 4.4. EEC plot of PLL helix unfolding in the presence of 0.5 M excipient, 31and
increasing urea concentrations ranging from 0, 0.25, 0.5 and 1M urea. Data was collected via
CD and T=298K of the TΔΔS term.
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CHAPTER 5: APPLICATION OF PLL MODEL TO MODEL PROTEIN BOVINE SERUM
ALBUMIN

5.1 Introduction
Proteins are large, complex macromolecules liable towards deformation, aggregation, and
loss of activity. As such, much effort in understanding stresses leading to deformation, how to
prevent it, and how to stabilize the structure has been done. Much of this work has gone into
identifying problematic sequences, hydrophobic patches, and other liable features. Despite the
importance of conformational maintenance in both form and function of protein based biologics,
relatively little work has gone into specifically understanding secondary structure stabilization of
various excipients. Once more, since peptide/protein based biologics are so fragile, large, and
often need to be administered at high concentrations (meaning viscosity, solubility and stability
challenges are exacerbated), many excipients are added to aid formulation properties and
maintain stability. This means stabilization/destabilization of secondary structure such as helices
likely experience a number of forces which can stabilize/destabilize their structure, therefore, a
suitable protein containing a large percentage of alpha helices as its overall SS content is desired
while also being amenable to thermal denaturation studies as such techniques are mainstays in
assessing stability.
5.2 The Model Protein BSA
BSA is a common and a well-studied protein, commonly used as an analog for proteins in
general to understand protein behavior such as folding, aggregation, excipient protein
interactions, and cellular transport processes, to name a few applications62, 132-137. BSA has been
extensively studied through thermal denaturation studies62, 134, 135, 137, 138. BSA is a large globular
protein with a molecular weight of 66,400 kDa, consisting of 584 amino acids, approximately
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60% helicity, 10% turn, with the rest random coil/extended chain and no ß-sheet SS

135, 137, 138

(Figure 5.1). The overall shape is oblate consisting of three domains, each stabilized by internal
di-sulfide bonds135. BSA contains a wide range hydrophilic and hydrophobic regions throughout
the molecule135, further enhancing its suitability as analog to general protein behavior.
In addition to high helical content and varied hydrophilicity, BSA has interesting and
well understood thermal denaturation behavior. For instance, thermal unfolding begins with
unfolding of short, interconnecting chains of I and IIa and IIb and IIIa, following further
unfolding resulting from the loss of alpha helicity of the molecule135. Unfolding is fully
reversible up to approximately 45-50 oC135, 138; however, for helices, full reversibility extends
from 52-60 oC135, 139 (FTIR analytical methods). Gel formation and other aggregation
phenomena begin to occur above 70 oC135. All loss in helicity is associated with a subsequent
increase in beta-sheets and random coil SS features. The former is of interest in that beta-sheet
SS is strongly associated with types of aggregation phenomina135, 140, and may be associated with
the observed aggregation and gel-formation behavior of BSA at higher temperatures. Given the
folding behavior, high helicity, and varied hydrophobicity of BSA, it makes a suitable test
protein to extend the previous peptide model to.
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Figure 5.1. X-ray crystallography structure of BSA rbc code: 4F5S (modified in pymol). 32 Here
region IIA and IIIA are circled as possible sites of initial helix and short segment unfolding as
assessed from FTIR studies135.

5.3 Materials and Method
BSA (≤95%), mannitol, PEG400, trehalose, urea, phosphate mono/di-basci, NaF and other
reagents were purchased from Siga-Aldrich, St. Louis, MO. Jasco. CD methods were the same
as that of the previous two chapters when assessing system #1 and #2 to evaluate thermodynamic
changes of helix unfolding.
5.3.1 CD Analysis
CD-UV analysis was done on a Jaso-810 CD spectrometer with an attached Peltier and 0.1 cm
quartz cuvette. CD spectra were recorded in triplicate with a scan rate of 100 nm/min, 1mm slit
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width with excipient/buffer solutions as blanks. HT values did not exceed 600 V for recorded
data. Full scan spectra were acquired from 200-260 nm at 25°C to evaluate SS features of BSA.
Additional full scans were run at 50, 75, and 90oC then re-run at 25oC to assess reversibility of
unfolding. Thermal denaturation to calculate free energy of unfolding was carried by ramping
the temperature from 25°C to 90°C at a rate of 0.5°C/min.
All data was collected in mdeg then converted to MRE using equation 5.29; fraction
helicity was then determined from equation 5.31 while equilibrium constant K and free energy
ΔG were determined from equations 5.24 and 5.17, respectively, for all data points using Excel
2016. Data was then plotted in Prism 6 using equation 5.36 and fitted with the LevenbergMarquardt.
5.4 Results and Discussion
5.4.1 CD Analysis of Secondary Structure
At 25oC BSA displays significant helicity (Figure 5.2) with the characteristic minima at
208 and 222 nm being observed. The helicity decreases as temperature increases, and at 75oC
and above, significant loss in helicity occurs as well, as can be seen in the coil/beta-sheet CD
profile in Figure 5.2. Importantly, like PLL, CD is a suitable analytical method to monitor
changes in helicity due to thermal denaturation.
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Figure 5.2. Full scan CD spectrum from 195-260 nm of 2 µM BSA in 0.1M PBS and 0.5M
mannitol at 25, 50, 75 and 90oC. 33

5.4.2 Effect of Temperature on BSA MRE and fH
BSA undergoing thermal and chemical challenges causes it to unfold. Monitoring
changes in helicity with CD is traditionally done through observing increasing MRE values at
222 nm, which is then correlated to fraction helicity using the mathematical relationships
discussed in the methods section of chapter 5. Data for the effect of mannitol concentration on
BSA MRE and fH is given in Figure 5.3 as a general example of this behavior. As can be seen,
MRE decreases with mannitol concentration in a concentration dependent manner, while the
corresponding fH increases as well. It can also be observed that the inflection point of the
sigmoidal curves indicating an increase in the Tm values increase with mannitol concentration.
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Figure 5.3. Effect of mannitol on BSA MRE (a) and fH (b).34

5.4.3 Effect of Thermal and Chemical Denaturation on BSA Unfolding Thermodynamics
Comparing thermodynamic helix stability in the presence and absence of excipients (i.e.
system #1 and #2, respectively) yielded several significant findings. Mannitol results are listed
and illustrated in Table 5.1, Table 5.2, and Figure 5.4, respectively. Interestingly, at low
mannitol concentrations, ΔΔH was slightly negative; however, this was more than compensated
entropically with an overall increase in free energy observed at these concentrations. At higher
concentrations, ΔΔH becomes positive while entropic stabilization decreases. Overall free
energy increases with concentration.
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7Table

5.1.
ΔΔX of mannitol on BSA.

Figure 5.4. ΔΔX effect of mannitol on BSA.35
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Trehalose on the other hand showed enthalpic stabilization at all concentrations as well as
entropic destabilization, offsetting much of the overall stabilization, as can be seen with the
relatively flat ΔΔG with concentration (Table 5.1, Table 5.2 and Figure 5.5).

Table 5.2.
ΔΔX of trehalose on BSA.8
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Figure 5.5. Trehalose effect on BSA unfolding ΔΔX. 36

Results for PEG400 are given in Table 5.1, Table 5.4, and Figure 5.6, respectively. Here,
enthalpic destabilization was somewhat offset by entropic stabilization. Overall, there is a slight
0.5-2 kcal/mol destabilization over the 0.1-0.1M PEG400 concentration.
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Table 5.3.
ΔΔX of PEG400 on BSA.9

Figure 5.6. PEG400 effect on BSA unfolding ΔΔX. 37

Interestingly, urea provided entropical stabilization as can be seen in Table 12.4 and
Figure 5.7 up to 1.5 M urea with ΔΔH values ranging from 53.9±1.52 kcal/mol at 0.25 M urea
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and 1.90±0.196 kcal/mol at 1.5 M urea (Table 5.5 and Figure 5.7). Entropically, it was
destabilized up to 1.5 M, with a concentration dependent decrease in destabilization; above 1.5
M it was entropically stabilized. Overall, from 0.1 to 0.5M urea stabilized BSA, with free
energy of 7.04±0.267 kcal/mol at 0.25 M urea being observed. Free energy stabilization
decreased to 3.14±0.112 kcal/mol at 0.5 M urea, then becoming negative and destabilized at 0.75
M urea with -0.524±0.132 kcal/mol free energy recorded (Table 5.7 and Figure 5.7), ultimately
becoming entropically destabilized at said urea concentration. Destabilization appears to be
entropically driven at 2 and 4M urea concentrations.
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Table 5.4.
ΔΔX of Urea on BSA.10

Figure 5.7. Urea effect on BSA unfolding ΔΔX.38
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Stabilization by urea at the lower concentrations was unexpected. Initially, it was
suspected that the low salt concentration of 0.1 M NaCl was insufficient to screen charges and
stabilize the protein and that perhaps urea at the low concentrations compensated for the low
NaCl concentration. Since the chloride ion absorbs UV light especially at far UV wavelengths83,
85

, it was decided to use NaF as it is a slightly stronger kosmotropic agent and has little effect on

CD UV absorption at the desired ranges. Given its stronger kosmotropic properties at similar
and higher concentrations, it would be expected that enthalpic stabilization by urea would be
reduced. Indeed, this was observed in Figure 5.8 where the ΔΔH was reduced from 53.9 to
approximately 25 kcal/mol, while entropic stabilization occurred at lower concentrations. ΔΔG
destabilization was much greater and occurred at 0.5 M to 4 M urea concentration.

Figure 5.8. NaF effect on ΔΔX on BSA unfolding and increasing urea concentration. Here parts
a-d represent changes in enthalpy, Tm, entropy, and free energy, respectively.39
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Since urea stabilization decreases at 0.1 M NaF relative to 0.1 M NaCl and stabilization
was greatest at the lowest urea concentrations, the experiments were repeated with BSA, 0.1M
urea and with a NaF concentration gradient of 0.01, 0.1 and 0.2 M NaF. NaF decreases ΔΔH
from 26.6±2.29 at 0.01M NaF to a negative value at 0.2M NaF kcal/mol to -0.100±1.80
kcal/mol; additionally, said decreases occur in a linear, concentration dependent manner (Table
5.5 and Figure 5.9). Likewise, TΔΔS stabilization effects decrease with NaF concentration in a
linear fashion, becoming destabilizing at 0.2M NaF with a value of -2.73± 0.255 kcal/mol.

Figure 5.9. Effect of increasing NaF on BSA stability at 0.1M urea. 40
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Table 5.5.
Effect of increasing NaF on BSA stability at 0.1M urea. 11

Further exploration of the urea stabilization phenomena revealed numerous literature
examples; Shiraga and company explored urea effects of urea on water structure utilizing broad
band terahertz NMR to explore its dual kosmotropic and chaotropic nature141. It was found that
up to 5M concentration, urea had a hydration number of 1.9, indicative of a constrained water by
a strong hydrogen exceptor141, showing kosmotropic properties. The tetrahedral nature of water
was preserved, albeit with it possessing a shorter lifetime; however, an increase in non-hydrogen
bonding was also observed141. Kosmotropic effects were attributed to the -NH2 urea
components, which significantly reduced the dynamics of the system, while chaotropic effects
were attributed to the -CO portion responsible for slight water structure perturbance141.
While urea can have both kosmotropic and chaotropic effects, its interaction with protein
is hotly debated74, 112, 141-144. In another NMR study, Otting et. al. used the nuclear Overhauoser
effect to measure urea binding to a bovine pancreatic trypsin inhibitor143, discovering that at low
temperatures it bound to specific regions; however, at higher temperatures this specificity
decreased, instead showing weak hydrogen bonding with the general protein in structure.143.
While not conclusive, such studies show the potential for favorable urea/protein interactions, that
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may explain in part urea’s enthalpic stabilization of BSA at low concentration and subsequent
enthalpic destabilization at high concentration. In another study addressing urea’s stabilizing
potential at low concentrations, Gull and company studied the effects of urea on a closely related
protein, human serum albumin (HSA), and found that it increased alpha helix content by 8%145.
It was conjectured stabilization was due to its effect on water structure (i.e. kosmotropic
effect141) and the lowering of the dielectric constant, thereby increasing the hydrophobic effect
enhancing alpha helix content145.
Given the mild kosmotropic nature of urea, its ability to form weak interactions with
protein surface and dielectric effects, it is understandable to see how it may stabilize a protein
enthalpically. Additionally, its effect on water structure could explain entropic stabilization. In
light of the discussed effects, it is not surprising that a stronger ionic kosmotrope such as NaF
could mask and mitigate urea stabilization. Another point of interest is the difference between
PLL and BSA. No such stabilization was observed for PLL. This is likely due to PLL already
having numerous neutral -NH2 side chains (due to the high pH of 11.7) that would minimize any
urea effects.
Plotting ΔΔH vs TΔΔS (T=298 K) reveals interesting effects of mannitol, trehalose,
PEG400, and urea on alpha helices unfolding behavior in BSA (Figure 5.10, Table 5.6).
Mannitol provides entropical stabilization (region III) up to 0.35 M mannitol, then becomes
enthalpically (region II) stabilized at 0.5 and 0.75M mannitol. This is in opposition to PLL,
which was ΔΔH stabilized at all concentrations. It is unclear why this would be the case. One
potential reason includes preferential interaction with BSA, which would be possible given the
relative heterogeneous nature of BSA compared to PLL. However, this seems unlikely given
that no such behavior was observed with trehalose. Trehalose behaves similarly to PLL, in
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which ΔΔH stabilization is observed but less in magnitude compared to mannitol, much like
what was observed in PLL (Figure 5.10)

Figure 5.10. EEC plot of BSA in presence of different concentrations of excipients. 41
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Table 5.6.
EEC classification by excipient and concentration.

PEG400 effect on BSA is much like that of PLL, in which enthalpic destabilization
(region IV) was observed for all concentrations with the exception of 0.75M, which enthalpically
stabilized PLL, but not BSA (Figure 4.8). BSA destabilization through PEG is not without
precedent having been noted by Arakawa6, 7 nearly 40 years ago, where it was hypothesized that
the -CH2- group interacted preferentially with BSA hydrophobic patches.
Urea, as discussed earlier, has complex interactions with both the protein and the solvent.
This is further illustrated in the enthalpy-entropy plot (Figure 5.10). At lower concentration
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region II (enthalpic), stabilization is observed but shifts to region IV (enthalpic destabilization) at
higher concentrations.
Ultimately, BSA alpha helix stabilization follows similar trends to that of PLL, such as
similar mannitol and trehalose ΔΔG stabilization magnitudes and similar PEG400
stabilization/destabilization. However, the thermodynamic mechanism differences in mannitol at
low concentrations was observed. For PLL, stabilization (at low concentration) was driven
enthalpically; BSA stabilization was entropically driven. Reasons for this difference are not
clear. Urea difference, i.e. stabilization of BSA at low concentration and no stabilization of PLL
at any concentration, is likely explained by the -NH2 side chain of PLL, which would negate the
-NH2 kosmotropic stabilization of urea.
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CHAPTER 6: GENERAL UNFOLDING OF BSA WITH DSC

6.1 Introduction
In the previous chapter, the effect of excipient on alpha helix stabilization was assessed
by directly measuring changes in helicity due to thermal stress using CD analytical methods.
Due to its ability to distinguish SS features in a protein, CD is an excellent analytical method to
assess thermodynamic effects of excipients on alpha helices located in a protein. However,
while BSA is largely composed of helices (coils and turns comprise the rest) it is a large protein
in which other stabilizing features such as sulfide bridges, hydrophobic core, and other large and
small structural features may factor into the thermodynamics of overall shape deformation. As
such, being able to assess excipient effects on overall ΔΔX properties is desirable in order to
differentiate between excipient effects on helices and gross structural changes.
In this light, DSC is the analytical method of choice due to its sensitivity to general
conformational change. Here, DSC is used to evaluate mannitol, trehalose, and PEG effects on
the comparative thermodynamics of BSA unfolding in their absence. There are several ways to
treat and model DSC data. In this chapter, a modified Zimm-Bragg model based off work by
Seelig and company39-43 was chosen due to its sequential unfolding methodology and robustness
towards a wide range of proteins and peptides39, 40 , behaving much how BSA does upon thermal
denaturation.
6.2 Materials and Methods
All reagents, BSA, PEG400, mannitol, trehalose, mono and dibasic phosphates were
purchased from Sigma Aldrich (Mo). All samples were run on a Waters TA Nano DSC.
Samples were run from 20oC to 90oC or at 35oC to 90oC (little change was observed between 25-
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35 C and 35 C was chosen as the starting temperature to expedite analysis) at a 0.5 C/min
temperature gradient. Samples were run at three excipient concentrations of 0.2, 0.5, and 0.75 M
in 0.01M phosphate buffer and 0.1M NaCl and a BSA protein concentration of 2 mg/ml.
The extent of unfolding was evaluated using said ZB model equation (5.25). Equation
5.25 is used since BSA is a large protein with more than 500 residues; thus, the matrix method
(equation 1.58) can be simplified to 1.65. In 1.65 the value s represents the propagation
parameter defined by equation (1.61), where h is the enthalpy of the elementary unfolding step
per residue and is given as 1.1 kcal/mol as that is the estimated enthalpy of formation per helix
residue39, 146. σ is the nucleation parameter (a penalizing factor for multiple helices in a given
sequence) and fitted to the data with values typically ranging from 10-4-10-9 while Tm is the
melting temperature and N is the number of residues in the molecule. The heat capacity at each
temperature is calculated through equation Z and fitted to the raw data through adjustment of the
parameters discussed. The ΔG is calculated through (equation 1.78) and ΔS and Tm calculated
same as discussed previously. Changes in free energy, enthalpy, and entropy are calculated as
before, i.e., ΔXnoexp -ΔXexp = ΔΔX. Data is then plotted and compared with CD and NMR
studies to deduce stabilization mechanisms through EEC plots.
6.3 Results and Discussion
Samples were run on the Waters Nano DSC as discussed, and below is the DSC
thermogram of BSA in the presence of 0.2M mannitol overlaid with the ZB estimated fraction
unfolded. As can be seen, the fraction unfolded inflection point matches the Tm of the raw and
ZB modeled data.
Mannitol increased ΔΔH but was somewhat offset by TΔΔS (T=298K) with overall ΔΔG
increase of 2-6 kcal/mol from 0.2 to 0.75 M mannitol ΔTm increased linearly with mannitol
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concentration (Figure 6.1). Looking at the EEC plot (Figure 6.5), mannitol net stabilization of
BSA is enthalpically driven (region II).
Trehalose, like mannitol, increased BSA stabilization enthalpically (Figure 6.2a) and
partially destabilized entropically (Figure 6.2b); a slight linear increase in ΔTm with respect to
trehalose concentration was observed (Figure 6.2c) and overall ΔΔG stabilization of
approximately 5.5 kcal/mol. Interestingly, most effects plateaued at the low concentration of
0.2M trehalose, with only slight changes at 0.5 and 0.75 M. As can be seen from the EEC plot
(Figure 6.5), trehalose stabilization mechanism is enthalpic (region II).
Much like the CD data, PEG400 effects were muted compared to mannitol and trehalose.
However, unlike the CD samples, the ΔΔH effects were slightly positive, though decreasing with
PEG concentration. Enthalpic stabilization was slight at 0.2M PEG400, decreasing 0.5M,
becoming negative at 0.75M. TΔΔS (T=298K) destabilization effects were observed for PEG,
which is to be expected given its purported crowding effects. Melting temperature decreases
with PEG400 concentration in a linear fashion. ΔΔG decreases with PEG400 concentration.
Looking at the EEC plot (Figure 6.5) it can be seen that it is slightly enthalpically stabilized
(region 2 at low mid concentration); however, it is somewhat destabilized at the higher end
through a combination of entropic and enthalpic effects (regions I and IV). As previously stated,
Arakawa many years ago noted PEGs have polar and hydrophobic components that may be both
repulsive and attractive towards different portions of a protein, complicating analysis of
stabilization/destabilization effects6. More recent study has looked at the effects of PEG (in this
case PEG 20) on the stabilization of ubiquitin16. Here, similar trends in enthalpy stabilization
were observed. PEG destabilization was observed and overall loss in free energy observed at
higher concentrations and decrease in Tm. Additionally it was concluded that PEG is both
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preferentially excluded and interacts with ubiquitin making overall stability somewhat
destabilized.
There are noticeable differences between CD and DSC. With DSC, changes in energy of
native vs denatured state are recorded (which incorporates effects from gross molecular
structural changes, salt-bridges etc.); CD only monitors changes in helicity or other secondary
structure features. When comparing EEC plots between the two, there are significant
differences. For DSC everything is enthalpically stabilized (region I) except PEG400 at high
concentration. CD, however, depended both on excipient type and concentration with
stabilization/destabilization occurring, happening over a number of different regions depending
on concentration. Such differences are important since specific changes in a protein/peptide can
have significant effects on aggregation rates and properties that might not be observed in DSC
type measurements.
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Figure 6.1. DSC scan of 2 mg/ml BSA in presence of 0.5M mannitol.42Black line is raw data
while the brown line is the ZB modeled data. The blue data line is the ZB modeled estimated
fraction folded.

137

Figure 6.2. Change in ΔΔX parameters determined from DSC analysis of 2 mg/ml BSA in the
presence of mannitol at 0.2, 0.5, 0.75M.43ΔΔH, TΔΔS (T=298 K), ΔTm, and ΔΔG is Figure a.,
b., c., d., respectively.
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Figure 6.3. Change in ΔΔX parameters determined from DSC analysis of 2 mg/ml BSA in the
presence of trehalose at 0.2, 0.5, 0.75M44where ΔΔH, TΔΔS (T=298 K), ΔTm, and ΔΔG is
Figure a., b., c., d., respectively.
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Figure 6.4. Change in ΔΔX parameters determined from DSC analysis of 2 mg/ml BSA in the
presence of PEG400 at 0.2, 0.5, 0.75M. 45where ΔΔH, TΔΔS (T=298 K), ΔTm, and ΔΔG is
Figure a., b., c., d., respectively.

Figure 6.5. DSC EEC plot of BSA in the presence of mannitol, trehalose, and PEG400.46

Comparing DSC and CD EEC plots, it can be seen there are similarities and differences
in the driving stabilizing/destabilizing mechanisms depending on the tested excipient (Figure 6.6,
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Table 6.1). For mannitol, medium and high concentrations show both region II (enthalpic
stabilization) while low concentrations differ, regions I/II for CD/DSC, respectively. Trehalose
results match across concentration ranges (region II), while PEG400 differ completely, regions
IV/I&II, respectively. Unlike PLL, BSA is composed of multiple helices, coils and turns;
additionally, it contains a variety of amino acid residue types and is over 20 times larger than the
PLL polymer chosen. Moreover, DSC measures calorimetric enthalpy ΔHcal, not ΔHv, and
accounts for overall unfolding, not just helix unfolding, and may account for other global
changes not observable in CD. Differences in DSC and CD unfolding measurements allows for
excipient effect on helix vs whole protein thermodynamic stabilization/destabilization to be
quantified. As can be seen in Figure 6.6 and Table 6.1 DSC values possess larger
enthalpic/entropic changes and differ in the driving stabilization/destabilization.
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Figure 6.6. BSA EEC plots CD vs DSC

Table 6.1.
BSA EEC plots CD vs DSC

142
CHAPTER 7: EFFECT OF EXCIPIENTS ON THE RECOVERY OF BSA HELICITY AFTER
THERMAL DENATURATION

7.1 Introduction
BSA, like nearly all proteins, is subject to aggregation upon denaturation. The greater, or
more frequently the native state transitions to the unfolded state, the greater the risk of
aggregation.

Many studies have reported on this phenomenon, describing the aggregation

process to occur due to loss of SS133, 135 and reduction in hydration layer147, beta-sheet cross
linking147, and other self-association mechanisms135, 138. The beta-sheet susceptibility towards
aggregation is particularly germane, given loss of helicity in BSA is converted directly to coils
and beta-sheets135, 139, meaning preservation of helicity through appropriate excipient additives
should reduce aggregation and improve structure recoverability after undergoing thermal stress.
As already seen, osmotic, surfactant, and crowding agents can have a dramatic effect not
only on the thermodynamics of unfolding but affect SS content as well. In addition to unfolding
and SS content, these additives can also alter the protein/peptide size and number and size of
aggregates. This has been demonstrated through various DLS studies such as Das’s study of
trehalose and glycerol on BSA conformation137, in which BSA in the presence of each excipient
exhibited two main species at approximately 10 nm and 200 nm for the monomeric and
aggregated species, respectively, in BSA only solutions. Trehalose reduced the monomer to
6.590 nm and 190.3 nm for the aggregated species for 0.5 M trehalose. Interestingly, CD
analysis showed a 3-4% increase in total helicity. 20% glycerol (same viscosity as 0.5 M
trehalose137), however, enlarged both the monomeric and aggregate BSA species. This is
unsurprising given the chemical similarity to the PEG400 molecule and its minimal
stabilization/destabilization effects observed in CD and DSC studies. BSA aggregation rates and
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size increased with temperature, especially after exceeding 60 C
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. Finally, Kishore et. al,

utilizing DSC experiments, noted the inhibition mechanism of osmolytes on BSA aggregation
listed here in decreasing inhibition: Hydroxyproline> Sorbitol> Sarcosine> Glycine betaine148.
Here, CD studies of BSA undergoing thermal denaturation at different temperature
increments in the presence of 0.5M mannitol, trehalose, or PEG400 were performed to assess
their respective abilities to preserve helical content in BSA after heating. Loss of helicity is
assumed to occur through aggregation and irreversible unfolding. Greater preservation of
helicity is attributed enhanced stability of helices and other features, which unfold less and
aggregate less.
7.2 Materials and Methods
BSA, trehalose, mannitol, PEG400, mono and dibasic sodium phosphate were purchased
through Sigma Aldrich (Mo). Samples were run on a Jasco-8 CD using a 0.1 crystal cuvette full
scan from 260-195 nm in triplicate, three scans each, at 50 nm/min at 25, 50, 75, and 90oC then
rerun at 25oC for the 50, 75 and 90oC. Fraction helicity was calculated at 222 nm as previously
discussed for past CD studies and compared to initial BSA 25oC to determine percent recovery.
7.3 Results and Discussion
Here, UV CD full scan of BSA upon heating at different temperatures in the presence of
0.5M mannitol is shown in Figure 7.1. Heating BSA to 50oC had very little effect on helicity
and overall secondary structure (dark blue), which is to be expected from both previous CD and
DSC studies as well as literature examples139. At 75oC, well past the transition temperature, the
CD profile changes significantly to one comprising large coil and beta-sheet SS structure content
(Figure 7.1). Though not shown here, 50oC rerun at 25oC showed full recovery; however, at
75oC (grey), samples rerun at 25oC had significant loss in fraction helicity and had greater coil
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content which was observed from the large negative peak at 205 nm (light blue). Samples run at
90oC (yellow) lost most of the original helicity. Rerunning said samples at 25oC showed little
recovery of original helicity.
BSA in the presence of 0.5M trehalose and PEG400 were carried out as well, and percent
recovery is shown in Figure 7.2. The BSA rerun after 75oC showed significant decrease in
fraction helicity across all samples, with different excipients, with values ranging from 77.6±8.83
for PEG400, 78.2±8.85, buffer only, 84.9±3.29 and 86.3±5.28 for trehalose and mannitol,
respectively (Figure 7.2 and Table 7.1). While trehalose and mannitol percent recovery trend
higher than buffer and PEG, there is no significance between them and buffer and PEG400.
These differences become significant after heating at 90oC with only 58.6±1.12 and 58.2±11.2
for buffer and PEG400, respectively, while mannitol and trehalose 76.7±2.58 and 76.4±4.99,
respectively (Table 7.2).
Increased stabilization of helices in BSA from mannitol and trehalose means that there is
less helices unfolding and converting to coils/beta sheet SS,135-137, 144, 147, 149 thereby decreasing
the rate of aggregation which bears out in the data presented in Figures 6.1-6.2 and Table 6.
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Figure 7.1. Far-UV full scan of BSA in the presence of 0.5M mannitol run at 25, 50, 75 and
90oC increments then rerun at 25oC (n=3).47
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Figure 7.2. Fraction helicity recovered after heating BSA at 75oC and 90oC and rerun at 25oC.48

Table 7.1.
Percent recovery of BSA after heating in presence of 0.5M mannitol, trehalose, PEG400. 12
Temp
75oC
90oC

Buffer
78.2±8.85
58.6±1.12

Mannitol
84.9±3.29
76.7±2.58

Trehalose
86.3±5.28
76.4±4.99

PEG400
77.6±8.83
58.6±11.2

7.4 Summary and Conclusion
Stabilization by mannitol and trehalose reduces the concentration of unfolded helices of
BSA, thereby reducing the amount of coil present in a given time frame to irreversibly fold into
beta-sheet configuration allowing for less denaturation and greater recovery upon cooling.
Likewise, PEG400 destabilizes helix structure (from possible interactions with hydrophobic
patches of BSA) allowing for more irreversible helix unfolding.
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CHAPTER 8: GENERAL DISCUSSION AND CONCLUDING REMARKS

Protein/peptide based biologics are large, complex, fragile molecules that often need to
be delivered at high concentrations, need to be highly soluble, maintained at specific and narrow
pH ranges, and often have poor shelf-life/transportation stability. As such, many excipients are
added to biologic formulations to boost their performance, storage, and compliance profiles.
These excipients can have profound effects on stability and performance as a whole and require
much time and effort in order to optimize a formulation. Because of such challenges, much
effort has gone into better understanding their mechanisms of stabilization of proteins and
peptides, which are generally surmised to occur through preferential hydration and volume
exclusion mechanisms (in the liquid state). While the general mechanisms are well understood,
little effort has gone into understanding how excipients may stabilize individual features such as
SS. This is important as SS features are not static elements in a biologic therapeutic, but instead
are capable of unfolding and refolding. This is true of helices as well as other SS types and is
significant, because upon unfolding, they are more prone to self-association, other aggregation
phenomena, and degradation. In the case of helices, the more stabilized it is, the less time it will
spend unfolded and will be less likely to degrade or aggregate. Understanding and quantifying
mechanisms of stabilization will help expedite and improve the formulation process.
Proteins and peptides stability are largely assessed through thermal and chemical
denaturation studies and generally behave similarly one to another under such stresses. Because
of this, it was proposed to measure and classify common excipient effects on the thermodynamic
unfolding of alpha helices using a model peptide PLL and model protein BSA. PLL is a very
simple peptide polymer, that under appropriate pH and room temperature conditions will adapt a
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neutral alpha-helix. Given its homopolymer and simple nature, PLL is an excellent model to
assess excipient effects on helicity. BSA, is a highly helical protein that possesses a wide variety
of amino acid types, hydrophobic/hydrophilic regions, and is also susceptible to aggregation
which make it an excellent model protein. Model peptide and protein were tested with three
common excipients: mannitol (a sugar alcohol), trehalose (a disaccharide), and PEG 400 (a
polyol). All three excipients are ubiquitous in both liquid and solid formulations. All three are
purported to protect and interact with peptide/proteins differently. Moreover, all formulations
including solid formulations spend time as liquid formulation (reconstitution). Said peptide and
protein were then put through various thermal and chemical (urea denaturation) challenges to
measure excipient stabilization of alpha helices.
PLL CD studies showed CD could detect the alpha helix component of PLL, and that it
could monitor changes in helicity due to thermal stress. Moreover, CD studies on PLL revealed
that mannitol and trehalose protected helices enthalpically, with mannitol having a stronger
effect than trehalose. These trends were largely observed as well in BSA, with mannitol again
showing stronger overall stabilization than trehalose; however, at low concentrations, mannitol
appeared to stabilize more through entropic means than enthalpic. PEG effects were similar in
both. Not much change was observed in either, other than slight destabilization in both (except
at the highest PEG concentrations for PLL). PLL was enthalpically stabilized at 0.75 M
PEG400, while BSA was not, but PEG at its highest concentration did have some enthalpic
stabilization though it was more than offset by entropic destabilization. Urea, as expected, was
enthalpically destabilizing for PLL, but interestingly, at low to intermediate ranges, BSA was
stabilized by urea. Studies with NaF at high and low concentrations confirmed that increased
salt presence mitigated this stabilization effect. Furthermore, literature searches revealed that
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urea possess both kosmotropic (-NH2) and chaotropic (-CO) components and at low to
intermediate concentrations the kosmotrope stabilization can dominate. As to why stabilization
of PLL at low to mid urea concentration was not observed, it was attributed to the many -NH2 on
the lysine side chains which may mute the kosmotrope effects of urea -NH2.
For PLL, the ability of excipients to protect helicity against chemical denaturation was
assessed. 0.5M excipient (common concentrations of many formulations) were put with PLL
with different urea gradients. It was found that mannitol could protect against chemical
denaturation up to 0.5M urea. Trehalose behaved similarly but was less effective than mannitol.
When looking at EEC plots, mannitol and trehalose protected initially enthalpically (region II)
before becoming destabilized entropically or enthalpically (regions I and IV, respectively).
PEG400 had little effect and all PLL samples showed enthalpic destabilization (region IV).
The same experiment was repeated using NMR. For NMR, changes in chemical shift
were used to monitor change PLL helicity. Ultimately, it was shown that changes in helicity, as
monitored with NMR, trended with those of CD, though change in helicity increased faster with
NMR and there was not a perfect correlation with CD.
DSC studies were carried out with BSA due to its sensitivity and comprehensive ability
to account for all thermodynamic changes due to conformational change, allowing for
differences in alpha helix unfolding relative to general conformational changes. Such
differences in measuring thermodynamics of unfolding allow greater elucidation of helix effects
on helices. DSC results did indeed differ from those of CD. Mannitol and trehalose
enthalpically stabilized BSA at all concentrations while PEG was slightly destabilizing, showing
a mixture of Region II and IV stabilization/destabilization, respectively. Such differences are
attributed to the additional global features of the protein undergoing thermal denaturation.
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Maintaining SS structure in proteins, including helices, is vital in mitigating adverse
effects such as aggregation and degradation. Stabilizing excipients can serve in this function.
Heating and rerunning samples at 25oC revealed the ability of mannitol and trehalose to protect
BSA helicity while PEG400 and buffer showed greater loss of helicity. Such loss is purported to
occur from self-association of beta-sheets formed from helix to coil to beta-sheet transition.
Ultimately, it was shown that the use of a model peptide and protein could be used to
measure stabilization of alpha helices by excipients. This work is unique in that no previous
studies have specifically addressed alpha helix stabilization by excipients and is of particular
importance since it shows stabilization of helices can differ from excipient to excipient and from
other general features of a protein. Another important consideration is that of the complicated
nature of formulations. Categorizing excipient stabilization mechanisms at different
concentrations using EEC plots can be useful strategy while developing formulations.
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